Humangenetik_Bremen_Uni

2022

Bullerdiek J, Reisinger E, Rommel B, Dotzauer A (2022). ABO blood groups and the risk of SARS-CoV-2 infection. Protoplasma, online ahead of print. DOI

2021

Gottlieb A, Flor I, Nimzyk R, Burchardt L, Helmke B, Langenbuch M, Spiekermann M, Feidicker S, Bullerdiek J (2021, online 2020). The expression of miRNA encoded by C19MC and miR-371-3 strongly varies among individual placentas but does not differ between spontaneous and induced abortions. Protoplasma 258:209-218. DOI
Völkner C, Liedtke M., Petters J, Lukas J, Murua Escobar H, Knuebel G, Bullerdiek J, Holzmann C, Hermann A, Frech MJ (2021, online 2020). Generation of an iPSC line (AKOSi004-A) from fibroblasts of a female adult NPC1 patient, carrying the compound heterozygous mutation p.Val1023Serfs*15/p.Gly992Arg and of an iPSC line (AKOSi005-A) from a female adult control individual. Stem Cell Res 50:102127. DOI

2020

Bullerdiek J (2020). Blood type A associated with critical COVID-19 and death in a Swedish cohort - a critical comment. Crit Care 24:547. DOI
Bullerdiek J (2020). COVID-19 and blood groups – there is an elephant in the room, but who cares? Do we need additional rules for preprints? [version 1; peer review: 2 approved]. F1000Research 9:1139. DOI
Bullerdiek J (2020). COVID-19 challenging cell biology. Protoplasma 257:619-620. DOI
Bullerdiek J, Bock-Steinweg U (2020). Das GnRHR-Gen, seine Mutationen und deren Manifestation. Der Gynäkologe 53:502-509. DOI
Bullerdiek J, Holzmann C, Rommel B (2020). Die Rolle der HMGA-Proteine („high mobility group AT-hook“) bei Proliferation und Differenzierung mesenchymaler Zellen und Gewebe. Gefässchirurgie 25:332-338. DOI
Foraita R, Friemel J, Günther K, Behrens T, Bullerdiek J, Nimzyk R, Ahrens W, Didelez V (2020). Causal discovery of gene regulation with incomplete data. J R Statist Soc A 183:1747-1775. DOI
Holzmann C, Helmke B, Bullerdiek J (2020). Gross genetic alterations and genetic heterogeneity in a periductal stromal tumor of the breast. Mol Cytogenet 13:49.
Holzmann C, Kuepker W, Rommel B, Helmke B, Bullerdiek J (2020). Reasons to reconsider risk associated with power morcellation of uterine fibroids. In Vivo 34:1-9. DOI
Küpker W, Plathow D, Bullerdiek J, Felberbaum R (2020). Neue Behandlungsoptionen mit GnRH-Antagonisten bei Endometriose und Uterus myomatosus. Gynäkologische Endokrinologie 18:169-174. DOI
Petters J, Völkner C, Krohn S, Murua Escobar H, Bullerdiek J, Reuner U, Frech MJ, Hermann A, Lukas J (2020). Generation of two induced pluripotent stem cell lines from a female adult homozygous for the Wilson disease associated ATP7B variant p.H1069Q (AKOSi008-A) and a healthy control (AKOSi009-A). Stem Cell Res 49: 102079. DOI
Völkner C, Liedtke M, Petters J, Huth K, Knuebel G, Murua Escobar H, Bullerdiek J, Lukas J, Hermann A, Frech MJ (2020). Generation of an iPSC line (AKOSi006-A) from fibroblasts of a NPC1 patient, carrying the homozygous mutation p.I1061T (c.3182 T > C) and a control iPSC line (AKOSi007-A) using a non-integrating Sendai virus system. Stem Cell Res 49:102056. DOI

2019

Bullerdiek J (2019). Bacteria acting with tumorigenic chaperones. Protoplasma 256:291-292. DOI
Bullerdiek J, Küpker, W (2019). Myome – was liegt da in der DNA? Der Gynäkologe 52:288-294. DOI
Fehr A, Bullerdiek J, Jaekel T, Löning T (2019). Molecular characterization of salivary gland carcinomas. p. 17-32, in: Salivary Gland Cancer. Licitra, L., Locati, L. (eds.), Springer International Publishing, Basel, ISBN 978-3-030-02958-6

2018

Holzmann C, Saager C, Mechtersheimer G, Koczan D, Helmke BM, Bullerdiek J (2018). Malignant transformation of uterine leiomyoma to myxoid leiomyosarcoma after morcellation associated with ALK rearrangement and loss of 14q. Oncotarget 9:27595-27604. DOI
Bullerdiek J, Rommel B (2018). Factors targeting MED12 to drive tumorigenesis? [version 2; peer review: 2 approved, 1 approved with reservations]. F1000Research 2018, 7:359. DOI

2017

Allen CM, Bullerdiek J, Ro JY (2017). Congenital granular cell epulis. Chapter 4, p119. in: EL-Naggar AK, Chan JKC, Grandis JR, Slootweg PJ (Eds): WHO Classification of Head and Neck Tumours (4th edition). IARC: Lyon 2017, ISBN 978-92-832-2438-9
Baumhoer D, Bullerdiek J, Nicolai P (2017). Notochordal tumours. Chapter 2, p76. in: El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ (Eds): WHO Classification of Head and Neck Tumours (4th edition). IARC: Lyon 2017, ISBN 978-92-832-2438-9
Bell D, Bullerdiek J, Gnepp DR, Hunt JL (2017). Pleomorphic adenoma. Chapter 1, p33. in: El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ (Eds): WHO Classification of Head and Neck Tumours (4th edition). IARC: Lyon 2017, ISBN 978-92-832-2438-9
Bell D, Bullerdiek J, Gnepp DR, Schwartz MR, Stenman G, Triantafyllou A (2017). Pleomorphic adenoma. Chapter 7, p185-186. in: El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ (Eds): WHO Classification of Head and Neck Tumours (4th edition). IARC: Lyon 2017, ISBN 978-92-832-2438-9
Bell D, Bullerdiek J, Hunt JL (2017). Pleomorphic adenoma. Chapter 3, p99. in: El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ (Eds): WHO Classification of Head and Neck Tumours (4th edition). IARC: Lyon 2017, ISBN 978-92-832-2438-9
Bell D, Bullerdiek J, Katabi N (2017). Pleomorphic adenoma. Chapter 5, p139. in: El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ (Eds): WHO Classification of Head and Neck Tumours (4th edition). IARC: Lyon 2017, ISBN 978-92-832-2438-9
Bloch J, Holzmann C, Koczan D, Helmke BM, Bullerdiek J (2017). Loss of MED12-mutated leiomyoma cells occurs independent of passaging during in vitro growth. Oncotarget 137:123-128. DOI
Bullerdiek J (2017). Lipomas and Uterine Leiomyomas. Chapter in: Reference Module in Life Sciences, Elsevier, ISBN 9780128096338
Bullerdiek J, Bell D (2017). Synovial Sarcoma. Chapter 1, p41-42. in: El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ (Eds): WHO Classification of Head and Neck Tumours (4th edition). IARC: Lyon 2017, ISBN 978-92-832-2438-9
Bullerdiek J, Flucke U (2017). Lymphangioma. Chapter 4, p122-123. in: El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ (Eds): WHO Classification of Head and Neck Tumours (4th edition). IARC: Lyon 2017, ISBN 978-92-832-2438-9
Bullerdiek J, Flucke U (2017). Haemangioma. Chapter 4, p123. in: El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ (Eds): WHO Classification of Head and Neck Tumours (4th edition). IARC: Lyon 2017, ISBN 978-92-832-2438-9
Bullerdiek J, Flucke U, Franchi A, Thompson LDR (2017). Angiosarcoma. Chapter 1, p38-39. in: El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ (Eds): WHO Classification of Head and Neck Tumours (4th edition). IARC: Lyon 2017, ISBN 978-92-832-2438-9
Bullerdiek J, Ro JY, Thompson LDR (2017). Rhabdomyoma. Chapter 4, p122. in: El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ (Eds): WHO Classification of Head and Neck Tumours (4th edition). IARC: Lyon 2017, ISBN 978-92-832-2438-9
Flucke U, Bullerdiek J, Ihrler S (2017). Haemangioma. Chapter 7, p198. in: El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ (Eds): WHO Classification of Head and Neck Tumours (4th edition). IARC: Lyon 2017, ISBN 978-92-832-2438-9
Günther K, Foraita R, Friemel J, Günther F, Bullerdiek J, Nimzyk R, Markowski DN, Behrens T, Ahrens W (2017, online 2016). The stem cell factor HMGA2 is expressed in non-HPV associated head and neck squamous cell carcinoma and predicts patient survival of distinct subsites. Cancer Epidemiol Biomarkers Prev 26:197-205. DOI
Holzmann C, Koczan D, Loening T, Rommel B, Bullerdiek J (2017). Case Report: A low-grade uterine leiomyosarcoma showing multiple genetic aberrations including a bi-allelic loss of the retinoblastoma gene locus as well as germ-line uniparental disomy for part of the long arm of chromosome 22. Anticancer Res 37:2233. DOI
Ihrler S, Bullerdiek J, Flucke U (2017). Nodular fasciitis. Chapter 7, p199. in: El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ (Eds): WHO Classification of Head and Neck Tumours (4th edition). IARC: Lyon 2017, ISBN 978-92-832-2438-9
Ihrler S, Bullerdiek J, Flucke U, Wenig BM (2017). Lipoma/sialolipoma. Chapter 7, p198-199. in: El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ (Eds): WHO Classification of Head and Neck Tumours (4th edition). IARC: Lyon 2017, ISBN 978-92-832-2438-9
Thompson, LDR, Bullerdiek J, Flucke U, Franchi A. (2017). Leiomyoma. Chapter 1, p47. in: El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ (Eds): WHO Classification of Head and Neck Tumours (4th edition). IARC: Lyon 2017, ISBN 978-92-832-2438-9
Thompson, LDR, Bullerdiek J, Flucke U, Franchi A (2017). Haemangioma. Chapter 1, p47-48. in: El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ (Eds): WHO Classification of Head and Neck Tumours (4th edition). IARC: Lyon 2017, ISBN 978-92-832-2438-9
Thompson, LDR, Bullerdiek J, Flucke U, Franchi A (2017). Schwannoma. Chapter 1, p48-49. in: El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ (Eds): WHO Classification of Head and Neck Tumours (4th edition). IARC: Lyon 2017, ISBN 978-92-832-2438-9
Thompson, LDR, Bullerdiek J, Flucke U, Franchi A (2017). Neurofibroma. Chapter 1, p49-50. in: El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ (Eds): WHO Classification of Head and Neck Tumours (4th edition). IARC: Lyon 2017, ISBN 978-92-832-2438-9

2016

Bullerdiek J (2016). Somatische Mutationen bei Uterus-Myomen: Bedeutung für Pathogenese und klinische Relevanz. DKFZ Zeitschrift Einblick 1/2016:14.
Bullerdiek J, Dotzauer, A, Bauer, I (2016). The mitotic spindle: Linking teratogenic effects of Zika virus with human genetics? Mol Cytogenet 9:32. DOI
Dieckmann KP, Spiekermann M, Balks T, Ikogho R, Anheuser P, Wosniok W, Loening T, Bullerdiek J, Belge G. (2016) MicroRNA miR-371a-3p - A Novel Serum Biomarker of Testicular Germ Cell Tumors: Evidence for Specificity from Measurements in Testicular Vein Blood and in Neoplastic Hydrocele Fluid. Urol Int 97:76-83. DOI
Flor I, Spiekermann M, Löning T, Dieckmann KP, Belge G, Bullerdiek J (2016). Expression of microRNAs of C19MC in different histologic types of testicular germ cell tumours. Cancer Genomics Proteomics 13:281-289.
Friemel J, Foraita R, Günther K, Heibeck M, Günther F, Pflueger M, Pohlabeln H, Behrens T, Bullerdiek J, Nimzyk R, Ahrens W (2016). Pretreatment oral hygiene habits and survival of head and neck squamous cell carcinoma (HNSCC) patients. BMC Oral Health 16:33. DOI
Holzmann C, Löning T, Bullerdiek J (2016). Hyperhaploid uterine mesenchymal tumors - a novel genetic subgroup? Cancer Genet 209:278-281. DOI
Rommel B, Holzmann C, Bullerdiek J (2016). Malignant mesenchymal tumors of the uterus – time to advocate a genetic classification. Expert Rev Anticancer Ther 16:1155-1166. DOI

2015

Bullerdiek J (2015). Somatische Mutationen bei Uterus-Myomen: Bedeutung für Pathogenese und klinische Relevanz. GYNE 4: 22-24.
Bullerdiek J, Gisselsson, D (2015). Tumors of endocrine glands. In: Cancer Cytogenetics: Chromosomal and Molecular Genetic Aberrations of Tumor Cells, 4th Edition Editors-in-Chief: Sverre Heim and Felix Mitelman, Wiley-Blackwell, ISBN: 978-1-118-79553-8
Flor I, Bullerdiek J (2015). MicroRNAs als Mediatoren des embryomaternalen Dialogs. Gynäkologische Endokrinologie 13:110–114. DOI
Holzmann C, Markowski DN, Bartnitzke S, Koczan D, Helmke BM, Bullerdiek J (2015). A rare coincidence of different types of driver mutations among uterine leiomyomas (UL). Mol Cytogenet 8:76. DOI
Holzmann C, Markowski DN, von Leffern I, Löning C, Bullerdiek J (2015). Patterns of chromosomal abnormalities that can improve diagnosis of uterine smooth muscle tumors. Anticancer Res 35:6445-6456.
Kloth L, Gottlieb A, Helmke B, Wosniok W, Löning T, Burchardt K, Belge G, Günther K, Bullerdiek J (2015). HMGA2 expression distinguishes between different types of post-pubertal testicular germ cell tumours. J Pathol Clin Res 1:239-251. DOI

Markowski DN, Holzmann C, Bullerdiek J (2015). Genetic alterations in uterine fibroids - a new direction for pharmacological intervention? Expert Opin Ther Targets 21:1-10. DOI
Milting H, Klauke B, Christensen AH, Müsebeck J, Walhorn V, Grannemann S, Münnich T, Šarić T, Rasmussen TB, Jensen HK, Mogensen J, Baecker C, Romaker E, Laser KT, zu Knyphausen E, Kassner A, Gummert J, Judge DP, Connors S, Hodgkinson K, Young TL, van der Zwaag PA, van Tintelen JP, Anselmetti D (2015)(online 2014). The TMEM43 Newfoundland mutation p.S358L causing ARVC-5 was imported from Europe and increases the stiffness of the cell nucleus. Eur Heart J 36:872-881. DOI
Spiekermann M, Belge G, Winter N, Ikogho R, Balks T, Bullerdiek J, Dieckmann KP (2015, online 2014). MicroRNA miR-371a-3p in serum of patients with germ cell tumours: evaluations for establishing a serum biomarker. Andrology 3:78-84. DOI
Spiekermann M, Dieckmann KP, Balks T, Bullerdiek J, Belge G (2015). Is relative quantification dispensable for the measurement of microRNAs as serum biomarkers in germ cell tumors? Anticancer Res 35:117-121.
Vulto-van Silfhout AT, Nakagawa T, Bahi-Buisson N, Haas SA, Hu H, Bienek M, Vissers LE, Gilissen C, Tzschach A, Busche A, Müsebeck J, Rump P, Mathijssen IB, Avela K, Somer M, Doagu F, Philips AK, Rauch A, Baumer A, Voesenek K, Poirier K, Vigneron J, Amram D, Odent S, Nawara M, Obersztyn E, Lenart J, Charzewska A, Lebrun N, Fischer U, Nillesen WM, Yntema HG, Järvelä I, Ropers HH, de Vries BB, Brunner HG, van Bokhoven H, Raymond FL, Willemsen MA, Chelly J, Xiong Y, Barkovich AJ, Kalscheuer VM, Kleefstra T, de Brouwer AP. (2015). Variants in CUL4B are Associated with Cerebral Malformations. Hum Mutat 36:106-117. DOI

2014

Drosch M, Schmidt N, Markowski DN, Zollner TM, Koch M, Bullerdiek J (2014). The CD24hi smooth muscle subpopulation is the predominant fraction in uterine fibroids. Mol Hum Reprod 20:664-676. DOI
Holzmann C, Markowski, DN, Koczan D, Helmke BM, Bullerdiek J. (2014). Genome-wide acquired uniparental disomy as well as chromosomal gains and losses in an uterine epithelioid leiomyoma. Mol Cytogenet 7:19. DOI
Holzmann C, Markowski DN, Koczan D, Küpker W, Helmke BM, Bullerdiek J (2014). Cytogenetically normal uterine leiomyomas without MED12-mutations - a source to identify unknown mechanisms of the development of uterine smooth muscle tumors. Mol Cytogenet 7:88. DOI
Klemke M, Müller MH, Wosniok W, Markowski DN, Nimzyk R, Helmke BM, Bullerdiek J (2014). Correlated expression of HMGA2 and PLAG1 in thyroid tumors, uterine leiomyomas and experimental models. PLoS One 9:e88126. DOI
Markowski DN, Helmke BM, Bartnitzke S, Löning T, Bullerdiek J (2014). Uterine fibroids: do we deal with more than one disease? Int J Gynecol Pathol 33:568-572. DOI
Markowski DN, Tadayyon M, Bartnitzke S, Belge G, Helmke BM, Bullerdiek J (2014). Cell cultures in uterine leiomyomas: Rapid disappearance of cells carrying MED12 mutations. Genes Chromosomes Cancer 53:317-323. DOI
Thies HW, Nolte I, Wenk H, Mertens F, Bullerdiek J, Markowski DN (2014)(online 2013). Permanent activation of HMGA2 in lipomas mimics its temporal physiological activation linked to the gain of adipose tissue. Obesity (Silver Spring) 22:141-150. DOI

2013

Drosch M, Bullerdiek J, Zollner TM, Prinz F, Koch M, Schmidt N (2013). A novel mouse model that closely mimics human uterine leiomyomas. Fertil Steril 99:927-935. DOI
Gillis AJ, Rijlaarsdam MA, Eini R, Dorssers LC, Biermann K, Murray MJ, Nicholson JC, Coleman N, Dieckmann KP, Belge G, Bullerdiek J, Xu T, Bernard N, Looijenga LH (2013). Targeted serum miRNA (TSmiR) test for diagnosis and follow-up of (testicular) germ cell cancer patients: A proof of principle. Mol Oncol 7:1083-1092. DOI
Markowski DN, Bullerdiek J (2013). Chromothripsis in uterine leiomyomas. N. Engl. J. Med. 369:2160. DOI
Markowski DN, Huhle S, Nimzyk R, Stenman G, Löning T, Bullerdiek J (2013). MED12 mutations occurring in benign and malignant mammalian smooth muscle tumors. Genes Chromosomes Cancer 52:297-304. DOI
Markowski DN, Nimzyk R, Belge G, Löning T, Helmke BM, Bullerdiek J. (2013). Molecular topography of the MED12-deleted region in smooth muscle tumors: a possible link between non B-DNA structures and hypermutability. Mol Cytogenet 6:23. DOI
Markowski DN, Thies HW, Gottlieb A, Wenk H, Wischnewsky M, Bullerdiek J (2013). HMGA2 expression in white adipose tissue linking cellular senescence with diabetes. Genes Nutr 8:449-456. DOI
Müller MH, Drieschner N, Focken T, Bartnitzke S, Winter N, Klemke M, Bullerdiek J (2013). HMGA2 expression in the PC-3 prostate cancer cell line is autonomous of growth factor stimulation. Anticancer Res 33:3069-3078.

2012

Belge G, Dieckmann KP, Spiekermann M, Balks T, Bullerdiek J (2012). Serum levels of microRNAs miR-371-3: A novel class of serum biomarkers for testicular germ cell tumors? Eur Urol 61:1068-1069. DOI
Bullerdiek J, Flor I. (2012). Exosome-delivered microRNAs of "chromosome 19 microRNA cluster" as immunomodulators in pregnancy and tumorigenesis. Mol Cytogenet 5:27. DOI
Dieckmann, KP, Spiekermann M, Balks T, Flor I, Löning T, Bullerdiek J, Belge G (2012). MicroRNAs miR-371-3 in serum as diagnostic tools in the management of testicular germ cell tumours. Br J Cancer 107:1754-1760. DOI

Flor I, Bullerdiek J (2012). The dark side of a success story: microRNAs of the C19MC cluster in human tumours. J Pathol 227:270-274. DOI
Flor I, Neumann A, Freter C, Helmke BM, Langenbuch M, Rippe V, Bullerdiek J (2012). Abundant expression and hemimethylation of C19MC in cell cultures from placenta-derived stromal cells. Biochem Biophys Res Commun 422:411-416. DOI
Helmke BM, Markowski DN, Meyer A, Bullerdiek J (2012). The expression of HMGA2 varies strongly among colon carcinomas. Anticancer Res 32:1589-1593.
Kiefer Y, Schulte C, Tiemann M, Bullerdiek J (2012). Chronic lymphocytic leukemia-associated chromosomal abnormalities and miRNA deregulation. Appl Clin Genet 5:21-28. DOI

Klemke M, Drieschner N, Belge G, Burchardt K, Junker K, Bullerdiek J (2012). Detection of PAX8-PPARG fusion transcripts in archival thyroid carcinoma samples by conventional RT-PCR. Genes Chromosomes Cancer 51:402-408. DOI
Markowski DN., Bartnitzke S, Löning T, Drieschner N, Helmke BM, Bullerdiek J. (2012). MED12 mutations in uterine fibroids - their relationship to cytogenetic subgroups. Int J Cancer 131:1528-1536. DOI
Markowski DN, Helmke BM, Radtke A, Froeb J, Belge G, Bartnitzke S, Wosniok W, Czybulka-Jachertz I, Deichert U, Bullerdiek J (2012). Fibroid explants reveal a higher sensitivity against MDM2-inhibitor nutlin-3 than matching myometrium. BMC Womens Health 12: 2. DOI
Mohamed SA, Radtke A, Saraei R, Bullerdiek J, Sorani H, Nimzyk R, Karluss A, Sievers HH, Belge G (2012). Locally different endothelial nitric oxide synthase protein levels in ascending aortic aneurysms of bicuspid and tricuspid aortic valve. Cardiol Res Pract 2012:165957. DOI
Müller MH, Reimann-Berg N, Bullerdiek J, Murua Escobar H (2012). Genetic characterization of dogs via chromosomal analysis and array-based comparative genomic hybridization (aCGH). Tierärztl Prax Ausg K Kleintiere Heimtiere 40:55-58. DOI
Prabhune M, Belge G, Dotzauer A, Bullerdiek J, Radmacher M (2012). Comparison of mechanical properties of normal and malignant thyroid cells. Micron 43:1267-1272. DOI
Reimann-Berg N, Bullerdiek J, Murua Escobar H, Nolte I (2012). Chromosomenuntersuchungen bei Hunden (Chromosome analyses in dogs). Tierärztl Prax Ausg K Kleintiere Heimtiere 40:191-196. DOI
Rippe V, Flor I, Debler JW, Drieschner N, Rommel B, Krause D, Junker K, Bullerdiek J (2012). Activation of the two microRNA clusters C19MC and miR-371-3 does not play prominent role in thyroid cancer. Mol Cytogenet 5:40. DOI
Sendt W, Rippe V, Flor I, Drieschner N, Bullerdiek J (2012). Monosomy and ring chromosome 13 in a thyroid nodular goiter-do we underestimate its relevance in benign thyroid lesions? Cancer Genet 205:128-130. DOI
Sterenczak KA, Meier, M, Glage S, Meyer M, Willenbrock S, Wefstaedt P, Dorsch M, Bullerdiek J, Murua Escobar H, Hedrich H, Nolte I (2012). Longitudinal MRI contrast enhanced monitoring of early tumour development with manganese chloride (MnCl2) and superparamagnetic iron oxide nanoparticles (SPIOs) in a CT1258 based in vivo model of prostate cancer. BMC Cancer 12:284. DOI

Willenbrock S, Braun O, Baumgart J, Lange S, Junghanss C, Heisterkamp A, Nolte I, Bullerdiek J, Murua Escobar H (2012)(online 2011). TNF-α induced secretion of HMGB1 from non-immune canine mammary epithelial cells (MTH53A). Cytokine 57:210-220. DOI

2011

Belge G, Radtke A, Meyer A, Stegen I, Richardt D, Nimzyk R, Nigam V, Dendorfer A, Sievers HH, Tiemann M, Buchwalow I, Bullerdiek J, Mohamed SA (2011). Upregulation of the high mobility group AT-hook 2 gene in acute aortic dissection is potentially associated with endothelial-mesenchymal transition. Histol Histopathol 26:1029-1037. DOI
Bullerdiek J, Müsebeck J (2011). Prädiktive Diagnostik erblicher Tumordispositionen. Bremer Ärztejournal 64:13-14.
Drieschner N, Rippe V, Laabs A, Dittberner L, Nimzyk R, Junker K, Rommel B, Kiefer Y, Belge G, Bullerdiek J, Sendt W (2011). Interphase fluorescence in situ hybridization analysis detects a much higher rate of thyroid tumors with clonal cytogenetic deviations of the main cytogenetic subgroups than conventional cytogenetics. Cancer Genet 204:366-374. DOI
Helmke BM, Markowski, DN, Müller MH, Sommer A, Müller J, Möller C, Bullerdiek J (2011). HMGA proteins regulate the expression of FGF2 in uterine fibroids. Mol Hum Reprod 17:135-142. DOI
Klemke M, Drieschner N, Laabs A, Rippe V, Belge G, Bullerdiek J, Sendt W (2011). On the prevalence of the PAX8-PPARG fusion resulting from the chromosomal translocation t(2;3)(q13;p25) in adenomas of the thyroid. Cancer Genet 204:334-339. DOI
Kloth L, Belge G, Burchardt K, Loeschke S, Wosniok W, Fu X, Mohamed SA, Drieschner N, Rippe V, Bullerdiek J (2011). Decrease in thyroid adenoma associated (THADA) expression is a marker of dedifferentiation of thyroid tissue. BMC Clin Pathol 11:13. DOI
Markowski DN, Helmke BM, Belge G, Nimzyk R, Bartnitzke S, Deichert U, Bullerdiek J (2011). HMGA2 and p14Arf: major roles in cellular senescence of fibroids and therapeutic implications. Anticancer Res 31:753-761.
Markowski DN, Helmke BM, Meyer F, von Ahsen I, Nimzyk R, Nolte I, Bullerdiek J (2011). BMP4 increases expression of HMGA2 in mesenchymal stem cells. Cytokine 56:811-816. DOI
Markowski, DN, Winter N, Meyer F, von Ahsen I, Wenk H, Nolte I, Bullerdiek J (2011). p14(Arf) acts as an antagonist of HMGA2 in senescence of mesenchymal stem cells-implications for benign tumorigenesis. Genes Chromosomes Cancer 50:489-498. DOI

Reimann-Berg N, Murua Escobar H, Kiefer Y, Mischke R, Willenbrock S, Eberle N, Nolte I, Bullerdiek J (2011). Cytogenetic analysis of CpG-oligonucleotide DSP30 plus Interleukin-2-stimulated canine B-Cell lymphoma cells reveals the loss of one X chromosome as the sole abnormality.Cytogenet Genome Res 135:79-82. DOI
Reimann-Berg N, Willenbrock S, Murua Escobar H, Eberle N, Gerhauser I, Mischke R, Bullerdiek J, Nolte I (2011). Two new cases of polysomy 13 in canine prostate cancer. Cytogenet Genome Res 132:16-21. DOI
Richter A, Lübbing M, Frank H-G, Nolte I, Bullerdiek J, von Ahsen I (2011). High-mobility group protein HMGA2-derived fragments stimulate the proliferation of chondrocytes and adipose tissue-derived stem cells. Eur Cell Mater 21:355-363. DOI
Sterenczak KA, Kleinschmidt S, Wefstaedt P, Eberle N, Hewicker-Trautwein M, Bullerdiek J, Nolte I, Murua Escobar H (2011). Quantitative PCR and immunohistochemical analyses of HMGB1 and RAGE expression in canine disseminated histiocytic sarcoma (malignant histiocytosis). Anticancer Res 31: 1541-1548.
Winter N, Nimzyk R, Bösche C, Meyer A, Bullerdiek J. (2011). Chromatin immunoprecipitation to analyze DNA binding sites of HMGA2. PLoS One 6: e18837. DOI

2010

Bullerdiek J, Rommel B (2010). Comment Re: HMGA2 is a negative regulator of DNA-PK pathway. Cancer Res 10:1742. DOI
Gentschev I, Ehrig K, Donat U, Hess M, Rudolph S, Chen N, Yu YA, Zhang Q, Bullerdiek J, Nolte I, Stritzker J, Szalay AA (2010). Significant growth inhibition of canine mammary carcinoma xenografts following treatment with oncolytic vaccinia virus GLV-1h68. J Oncol 2010:736907. DOI
Hashemi Nezhad M, Drieschner N, Helms S, Meyer A, Tadayyon M, Klemke M, Belge G, Bartnitzke S, Burchardt K, Frantzen C, Schmidt EH, Bullerdiek J (2010). 6p21 rearrangements in uterine leiomyomas targeting HMGA1. Cancer Genet Cytogenet 203:247-252. DOI
Joetzke AE, Sterenczak KA, Eberle N, Wagner S, Soller JT, Nolte I, Bullerdiek J, Murua Escobar H, Simon D (2010). Expression of the high mobility group A1 (HMGA1) and A2 (HMGA2) genes in canine lymphoma: analysis of 23 cases and comparison to control cases.Vet Comp Oncol 8:87-95. DOI
Kiefer Y, Drieschner N, Förster H, Tiemann M, Schulte C, Rommel B, Bullerdiek J (2010). An unbalanced t(15;18)(q21-q22;p11) as the sole cytogenetic aberration in a patient with B-cell chronic lymphocytic leukemia.Cancer Genet Cytogenet 200:65-69. DOI
Klemke M, Meyer A, Hashemi Nezhad M, Belge G, Bartnitzke S, Bullerdiek J (2010). Loss of let-7 binding sites resulting from truncations of the 3' untranslated region of HMGA2 mRNA in uterine leiomyomas. Cancer Genet Cytogenet 196:119-123. DOI
Markowski DN, Bartnitzke S, Belge G, Drieschner N, Helmke BM, Bullerdiek J (2010). Cell culture and senescence in uterine fibroids.Cancer Genet Cytogenet 202:53-57. DOI
Markowski DN, Helmke BM, Bullerdiek J (2010). Cellular senescence in usual type uterine leiomyoma. Fertil Steril 94: e79. DOI
Markowski DN, von Ahsen I, Hashemi Nezhad M, Wosniok W, Helmke BM, Bullerdiek J (2010). HMGA2 and the p19Arf-TP53-CDKN1A axis: a delicate balance in the growth of uterine leiomyomas.Genes Chromosomes Cancer 49:661-668. DOI
Meyer A, Eberle N, Bullerdiek J, Nolte I, Simon D (2010). High-mobility group B1 proteins in canine lymphoma: prognostic value of initial and sequential serum levels in treatment outcome following combination chemotherapy.Vet Comp Oncol 8:127-137. DOI
Mohamed SA, Misfeld M, Hanke T, Charitos EI, Bullerdiek J, Belge G, Kuehnel W, Sievers HH (2010). Inhibition of caspase-3 differentially affects vascular smooth muscle cell apoptosis in the concave versus convex aortic sites in ascending aneurysms with a bicuspid aortic valve. Ann Anat 192:145-150. DOI
Rippe V, Dittberner L, Lorenz VN, Drieschner N, Nimzyk R, Sendt W, Junker K, Belge G, Bullerdiek J (2010). The two stem cell microRNA gene clusters C19MC and miR-371-3 are activated by specific chromosomal rearrangements in a subgroup of thyroid adenomas. PLoS One 5:e9485. DOI
Sterenczak KA, Joetzke AE, Willenbrock S, Eberle N, Lange S, Junghanss C, Nolte I, Bullerdiek J, Simon D, Murua Escobar H. (2010 ). High-mobility group B1 (HMGB1) and receptor for advanced glycation end-products (RAGE) expression in canine lymphoma. Anticancer Res 30:5043-5048.

2009

Bullerdiek J, Helmke BM (2009). Comment on 'HMGA2, MicroRNAs, and Stem Cell Aging'. Cell Online Comment
Fehr A, Meyer A, Heidorn K, Röser K, Löning T, Bullerdiek J (2009). A link between the expression of the stem cell marker HMGA2, grading, and the fusion CRTC1-MAML2 in mucoepidermoid carcinoma. Genes Chromosomes Cancer 48:777-785. DOI
Fehr A, Stenman G, Bullerdiek J, Löning T (2009). Molecular markers in salivary gland tumors: Their use in diagnostic and prognostic workup. Pathologe 30:466-471. DOI
Gentschev I, Stritzker J, Hofmann E, Weibel S, Yu YA, Chen N, Zhang Q, Bullerdiek J, Nolte I, Szalay AA (2009)(online 2008). Use of an oncolytic vaccinia virus for the treatment of canine breast cancer in nude mice: preclinical development of a therapeutic agent. Cancer Gene Ther 16:320-328. DOI
Hauschild G, Muschter N, Richter A, Ahrens H, Gosheger G, Fehr M, Bullerdiek J (2009). Cartilage replacement in dogs. Vet Comp Orthop Traumatol 22:216-221. DOI
Klemke M, Meyer A, Hashemi Nezhad M, Bartnitzke S, Drieschner N, Frantzen C, Schmidt E-H, Belge G, Bullerdiek J (2009)(online 2008). Overexpression of HMGA2 in uterine leiomyomas points to its general role for the pathogenesis of the disease. Genes Chromosomes Cancer 48:171-178. DOI
Lacbawan F, Solomon BD, Roessler E, El-Jaick K, Domené S, Vélez JI, Zhou N, Hadley D, Balog JZ, Long R, Fryer A, Smith W, Omar S, McLean SD, Clarkson K, Lichty A, Clegg NJ, Delgado MR, Levey E, Stashinko E, Potocki L, Vanallen MI, Clayton-Smith J, Donnai D, Bianchi DW, Juliusson PB, Njølstad PR, Brunner HG, Carey JC, Hehr U, Müsebeck J, Wieacker PF, Postra A, Hennekam RC, van den Boogaard MJ, van Haeringen A, Paulussen A, Herbergs J, Schrander-Stumpel CT, Janecke AR, Chitayat D, Hahn J, McDonald-McGinn DM, Zackai EH, Dobyns WB, Muenke M (2009). Clinical spectrum of SIX3-associated mutations in holoprosencephaly: correlation between genotype, phenotype and function. J Med Genet 46:389-398. DOI
Mohamed SA, Sievers HH, Hanke T, Richardt D, Schmidtke C, Charitos EI, Belge G, Bullerdiek J (2009). Pathway analysis of differentially expressed genes in patients with acute aortic dissection. Biomark Insights 4:81-90. DOI
Pavlova A, Brondke H, Müsebeck J, Pollmann H, Srivastava A, Oldenburg J (2009). Molecular mechanisms underlying hemophilia A phenotype in seven females. J Thromb Haemost 7:976-982. DOI
Petersen S, Soller JT, Wagner S, Richter A, Bullerdiek J, Nolte I, Barcikowski S, Murua Escobar H (2009). Co-transfection of plasmid DNA and laser-generated gold nanoparticles does not disturb the bioactivity of GFP-HMGB1 fusion protein. J Nanobiotechnology 7:6. DOI
Richter A, Hauschild G, Murua Escobar H, Nolte I, Bullerdiek J (2009)(online 2008). Application of high-mobility-group-A proteins increases the proliferative activity of chondrocytes in vitro. Tissue Eng Part A 15:473-477. DOI
Sterenczak KA, Willenbrock S, Barann M, Klemke M, Soller JT, Eberle N, Nolte I, Bullerdiek J, Murua Escobar H (2009)(online 2008). Cloning, characterisation, and comparative quantitative expression analyses of receptor for advanced glycation end products (RAGE) transcript forms. Gene 434:35-42. DOI
Verdorfer I, Fehr A, Bullerdiek J, Scholz N, Brunner A, Krugmann J, Hager M, Haufe H, Mikuz G, Scholtz A (2009). Chromosomal imbalances, 11q21 rearrangement and MECT1-MAML2 fusion transcript in mucoepidermoid carcinomas of the salivary gland. Oncol Rep 22:305-11. DOI
Winter N, Meyer A, Richter A, Krisponeit D, Bullerdiek J (2009). Elevated levels of HMGB1 in cancerous and inflammatory effusions. Anticancer Res 29:5013-5017.

2008

Altmann S, Lange S, Pommerencke J, Murua Escobar H, Bullerdiek J, Nolte I, Freund M, Junghanss C (2008). High Mobility Group Box 1-Protein expression in canine haematopoietic cells and influence on canine peripheral blood mononuclear cell proliferative activity. Vet Immunol Immunopathol 126:367-372. DOI
Belge G, Meyer A, Klemke M, Burchardt K, Stern C, Wosniok W, Loeschke S, Bullerdiek J (2008).Upregulation of HMGA2 in thyroid carcinomas: A novel molecular marker to distinguish between benign and malignant follicular neoplasias. Genes Chromosomes Cancer 47:56-63. DOI
Beuing C, Soller JT, Muth M, Wagner S, Dolf G, Schelling C, Richter A, Willenbrock S, Reimann-Berg N, Winkler S, Nolte I, Bullerdiek J, Murua Escobar H (2008). Genomic characterisation, chromosomal assignment and in vivo localisation of the canine high mobility group A1 (HMGA1) gene. BMC Genet 9:49. DOI
Fehr A, Röser K, Heidorn K, Hallas C, Löning T, Bullerdiek J (2008). A new type of MAML2 fusion in mucoepidermoid carcinoma. Genes Chromosomes Cancer 47:203-206. DOI
Fehr A, Röser K, Belge G, Löning T, Bullerdiek J (2008). A closer look at Warthin tumors and the t(11;19). Cancer Genet Cytogenet 180:135-139. DOI
Fork MAM, Murua Escobar H, Soller JT, Sterenczak KA, Willenbrock S, Winkler S, Dorsch M, Reimann-Berg N, Hedrich HHJ, Bullerdiek J, Nolte I (2008). Establishing an in vivo model of canine prostate carcinoma using the new cell line CT1258. BMC Cancer 8:240. DOI
Hafner C, Vogt T, Landthaler M, Müsebeck J (2008). FGFR3 and PIK3CA mutations are present in familial seborrheic keratoses. Br J Dermatol 159:214-217. DOI
Meyer A, Staratschek-Jox A, Springwald A, Wenk H, Wolf J, Wickenhauser C, Bullerdiek J (2008). Non-Hodgkin lymphoma expressing high levels of the danger-signalling protein HMGB1. Leuk Lymphoma 49:1184-1189. DOI
Reimann-Berg N, Murua Escobar H, Nolte I, Bullerdiek J (2008). Testicular tumor in an XXY dog. Cancer Genet Cytogenet 183:114-116. DOI
Soller JT, Beuing C, Murua Escobar H, Winkler S, Reimann-Berg N, Drieschner N, Dolf G, Schelling C, Nolte I, Bullerdiek J (2008).Chromosomal assignment of canine THADA gene to CFA 10q25.Mol Cytogenet 1:11. DOI
Von Ahsen I, Nimzyk R, Klemke M, Bullerdiek J (2008). A microRNA encoded in a highly conserved part of the mammalian HMGA2 gene. Cancer Genet Cytogenet 187:43-44. DOI
Winter N, Neumann A, Bullerdiek J (2008). Cell-free DNA in amniotic fluid remains to be attached to HMGA2 - implications for non-invasive prenatal diagnosis. Prenat Diagn 28:1126-1130. DOI

2007

Drieschner N, Kerschling S, Soller JT, Rippe V, Belge G, Bullerdiek J, Nimzyk R (2007). A domain of the thyroid adenoma associated gene (THADA) conserved in vertebrates becomes destroyed by chromosomal rearrangements observed in thyroid adenomas. Gene 403:110-117. DOI
Jensen J, Simon D, Murua Escobar H, Soller JT, Bullerdiek J, Beelitz P, Pfister K, Nolte I (2007). Anaplasma phagocytophilum in dogs in Germany. Zoonoses Public Health 54:94-101. DOI
Meyer B, Krisponeit D, Junghanss C, Murua Escobar H, Bullerdiek J (2007). Quantitative expression analysis in peripheral blood of patients with chronic myeloid leukaemia: Correlation between HMGA2 expression and white blood cell count. Leuk Lymphoma 48:2008-2013. DOI
Meyer B, Loeschke S, Schultze A, Weigel T, Sandkamp M, Goldmann T, Vollmer E, Bullerdiek J (2007). HMGA2 overexpression in non-small cell lung cancer. Mol Carcinog 46:503-511. DOI
Mohamed, SA., Misfeld M., Hanke, T, Belge G, Bullerdiek J, Sievers HH. (2007). Quadricuspid aortic valve in a patient with Turner syndrome. Exp Clin Cardiol 12:161-162. PMCID
Ostersehlt D, Rippe V (2007). Drei Spritzen gegen Krebs. Unterrichtsmodell Sekundarstufe I/II Unterricht Biologie 330: 37-44.
Soller JT, Murua Escobar H, Willenbrock S, Janssen M, Eberle N, Bullerdiek J., Nolte I (2007). Comparison of the human and canine cytokines IL-1(α/ß) and TNF-α to orthologous other mammalians. J Heredity 98:485-490. DOI
Winkler S, Murua Escobar H, Meyer B, Simon D, Eberle N, Baumgartner W, Loeschke S, Nolte I, Bullerdiek J (2007). HMGA2 expression in a canine model of prostate cancer. Cancer Genet Cytogenet 177:98-102. DOI

2006

Bullerdiek J (2006). Moderne Methoden in der Genomforschung und Humangenetik (Research into the human genome driven by improved methods). Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 49:989-994. DOI
Drieschner N, Belge G, Rippe V, Meiboom M, Loeschke S, Bullerdiek J (2006). Evidence for a 3p25 breakpoint hot spot region in thyroid tumors of follicular origin. Thyroid 16:1091-1096. DOI
Murua Escobar H, Soller JT, Sterenczak KA, Sperveslage JD, Schlueter C, Burchardt B, Eberle N, Fork M, Nimzyk R, Winkler S, Nolte I, Bullerdiek J (2006). Cloning and characterization of the canine receptor for advanced glycation end products. Gene 369:45-52. DOI
Rooryck C, Roudaut C, Robine E, Müsebeck J, Arveiler B (2006). Oculocutaneous albinism with TYRP1 gene mutations in a Caucasian patient. Pigment Cell Res 19:239-242. DOI
Soller JT, Murua Escobar H, Janssen M, Fork M, Bullerdiek J, Nolte I (2006). Cytokine genes single nucleotide polymorphism (SNP) screening analyses in canine malignant histiocytosis. Anticancer Res 26:3417-3420.
Von Ahsen I, Rogalla P, Bullerdiek J (2006). Germ line mutations of the HMGA2 gene are rare among the general population. Anticancer Res 26:3289-3292.
Winkler S, Reimann-Berg N, Murua Escobar H, Loeschke S, Eberle N, Höinghaus R, Nolte I, Bullerdiek J (2006). Polysomy 13 in a canine prostate carcinoma underlining its significance in the development of prostate cancer. Cancer Genet Cytogenet 169:154-158. DOI

2005

Bauer T, Rubehn B, Ostendorf A, Chichkov BN, Bullerdiek J, Nolte I, Hauschild G (2005). Generation of three-dimensional polymeric micro-structures for surface vitalization by Two-Photon-Polymerization. Proc 6th Int Symp Laser Precision Microfabrication (LPM2005)1:1-4.
Hauke S, Leopold S, Schlueter C, Flohr AM, Murua Escobar H, Rogalla P, Bullerdiek J (2005). Extensive expression studies revealed a complex alternative splicing pattern of the HMGA2 gene. Biochim Biophys Acta 1729:24-31. DOI
Kuechler A, Ziegler M, Blank C, Rommel B, Bullerdiek J, Ahrens J, Claussen U, Liehr T (2005). A highly complex chromosomal rearrangement between five chromosomes in a healthy female diagnosed in preparation for intracytoplasmatic sperm injection. J Histochem Cytochem 53:355-357. DOI
Martins C, Fonseca I, Roque L, Pereira T, Ribeiro C, Bullerdiek J, Soares J (2005). PLAG1 gene alterations in salivary gland pleomorphic adenoma and carcinoma ex-pleomorphic adenoma: a combined study using chromosome banding, in situ hybridization and immunocytochemistry. Mod Pathol 18:1048-1055. DOI
Mohamed SA, Hanke T, Schlueter C, Bullerdiek J, Sievers HH (2005). Ubiquitin fusion degradation 1-like gene dysregulation in bicuspid aortic valve. J Thorac Cardiovasc Surg 130:1531-1536. DOI
Murua Escobar H, Soller JT, Richter A, Meyer B, Winkler S, Bullerdiek J, Nolte I (2005). “Best friends” sharing the HMGA1 Gene: Comparison of the human and canine HMGA1 to orthologous other species. J Heredity 96:777-781. DOI
Richter A, Murua Escobar H, Günther K, Soller JT, Winkler S, Nolte I, Bullerdiek J (2005). RAS-gene hot-spot mutations in canine neoplasias. J Heredity 96:764-765. DOI
Röser K, Jäkel KT, Bullerdiek J, Löning T. (2005). Bedeutung molekular-zytogenetischer Befunde bei Speicheldrüsentumoren am Beispiel des Mukoepidermoidkarzinoms. Pathologe 26:359-366. DOI
Schlueter C, Hauke S, Loeschke S, Wenk HH, Bullerdiek J (2005). HMGA1 proteins in human atherosclerotic plaques. Pathol Res Pract 201:101-107. DOI
Schlueter C, Weber H, Meyer B, Rogalla P, Röser K, Hauke S, Bullerdiek J (2005). Angiogenetic signaling through hypoxia: HMGB1: An angiogenetic switch molecule. Am J Pathol 166:1259-1263. DOI
von Ahsen I, Rogalla P, Bullerdiek J (2005). Expression patterns of the LPP-HMGA2 fusion transcript in pulmonary chondroid hamartomas with t(3;12)(q27-28;q14-15). Cancer Genet Cytogenet 163:68-70. DOI
Winkler S, Murua Escobar H, Eberle N, Reimann-Berg N, Nolte I, Bullerdiek J (2005). Establishment of a cell line derived from a canine prostate carcinoma with a highly rearranged karyotype.J Hered 96:782-785. DOI
Winkler S, Murua Escobar H, Reimann-Berg N, Bullerdiek J, Nolte, I. (2005). Cytogenetic investigations in four canine lymphomas. Anticancer Res 25:3995-3998.
Zorn-Kruppa M, Tykhonova S, Belge G, Bednarz J, Diehl HA, Engelke M (2005). A human corneal equivalent constructed from SV40-immortalised corneal cell lines. Altern Lab Anim 33:37-45. DOI

2004

Chan JKC, Hirokawa M, Evans H, Williams ED, Osamura Y, Cady B, Sabrinho-Simoes M, Derwahl M, Paschke R, Belge G, Oriola J, Studer H, Eng C, Asa SL, Lloyd RV, Baloch Z, Ghossein R, Mazzaferri E, Fagin JA (2004). Follicular adenoma. pp:98-103. In: DeLellis R, Heitz P, Lloyd R, Eng C (Hrsg.): WHO classification of tumors. Pathology and genetics of tumors of endocrine organs. IARC Press, Lyon
Goldmann T, Flohr AM, Murua Escobar H, Gerstmayer B, Janssen U, Bosio A, Loeschke S, Vollmer E, Bullerdiek J (2004). The HOPE-technique permits Northern blot and microarray analyses in paraffin-embedded tissues. Pathol Res Pract 200:511-515. DOI
Meiboom M, Murua Escobar H, Winkler S, Nolte I, Bullerdiek J (2004). Molecular characterization and mapping of the canine KRAB zinc finger gene ZNF331. Anim Genet 35:262-263. DOI
Meyer B, Murua Escobar H, Hauke S, Richter A, Winkler S, Rogalla P, Flohr AM, Bullerdiek J, Nolte I (2004). Expression pattern of the HMGB1 gene in sarcomas of the dog. Anticancer Res 24:707-710.
Meyer B, Murua Escobar H, Winkler S, Dolf G, Schelling C, Bullerdiek J, Nolte I (2004). Molecular characterisation and mapping of the canine Cyclin D1 (CCND1). Anim Genet 35:413. DOI
Meyer J, Murua Escobar H, Bartnitzke S, Schelling C, Dolf G, Nolte I, Bullerdiek J (2004). The FAS-activated serine/threonine kinase gene (FASTK) maps to canine chromosome 16. Anim Genet 35:497. DOI
Murua Escobar H, Günther K, Richter A, Soller JT, Winkler S, Nolte I, Bullerdiek J (2004). Absence of ras-gene hotspot mutations in canine fibrosarcomas and melanomas. Anticancer Res 24:3027-3028.
Murua Escobar H, Meyer J, Winkler S, Schelling C, Dolf G, Nolte I, Bullerdiek J (2004). The protein kinase B, gamma (AKT3) gene maps to canine chromosome 7. Anim Genet 35:354-355. DOI
Murua Escobar H, Soller JT, Richter A, Meyer B, Winkler S, Flohr AM, Nolte I, Bullerdiek J. (2004). The canine HMGA1. Gene 330:93-99. DOI
Richter A, Murua Escobar H, Günther K, Meyer B, Winkler S, Dolf G, Schelling C, Nolte I, Bullerdiek J (2004). The canine NRAS gene maps to CFA 17. Anim Genet 35:355-356. DOI
Santos SE, Murua Escobar H, Sider LH, Winkler S, Aoki SM, Milazzotto MP, Campagnari F, Vannucchi CI, Bullerdiek J, Nolte I, Garcia JF (2004). DNA sequence, polymorphism, and mapping of luteinizing hormone receptor fragment (LHCGR) gene in Great Dane dogs. Anim Genet 35:74-75. DOI
Tzschach A, Hoeltzenbein M , Bache I, Tinschert S, Bommer C, Körner H, Thiel G, Müsebeck J, Grimm T, Henn E, Brude E, Krüger M, Leube B, Schulze B, Schwanitz G, Raff R, Dufke A, Wolff G, Latos-Bielenska A, Ebner S, Kossakiewicz M, Fuchs S, Barbi G, Köhler A, Wand D (2004). Late-onset diseases among carriers of balanced chromosome rearrangements – results of a multicentre survey. Eur J Hum Genet 12:133-134.
Winkler S, Murua Escobar H, Günther K, Richter A, Dolf G, S.chelling C, Bullerdiek J, Nolte I (2004). The canine KRAS2 gene maps to chromosome 22. Anim Genet 35:350-351. DOI
Zorn-Kruppa M, Tykhonova S, Belge G, Diehl HA, Engelke M (2004). Comparison of human corneal cell cultures in cytotoxicity testing. ALTEX 21:129-134.

2003

Bamberger A-M, Makrigiannakis A, Röser K, Radde J, Karstens T, Flohr AM, Bamberger CM, Bullerdiek J, Löning T (2003). Expression of the high-mobility group protein HMGI(Y) in human trophoblast: potential role in trophoblast invasion of maternal tissue. Virchows Archiv 443:649-654. DOI
Becker K, Murua Escobar H, Richter A, Meyer B, Nolte I, Bullerdiek J (2003). The canine HMGA1 gene maps to CFA 23. Anim Genet 34:68-69. DOI
Borrmann L, Schwanbeck R, Heyduk T, Seebeck B, Rogalla P, Bullerdiek J, Wisniewski JR (2003). High mobility group A2 protein and its derivatives bind a specific region of the promoter of DNA repair gene ERCC1 and modulate its activity. Nucl Acids Res 31:6841-6851. DOI
Borrmann L, Seebeck B, Rogalla P, Bullerdiek J (2003). The human HMGA2 promoter is regulated by a polymorphic dinucleotide (TC)-repeat. Oncogene 22:756-760. DOI
Flohr AM, Hackenbeck T, Schlüter C, Rogalla P, Bullerdiek J (2003). DNase I treatment of cDNA first-strands prevents RT-PCR amplification of contaminating DNA sequences. BioTechniques 35:920-922, 924, 926. DOI
Flohr, AM, Rogalla P, Bonk U, Puettmann B, Buerger H, Gohla G, Packeisen J, Wosniok W, Loeschke S, Bullerdiek J (2003). High mobility group protein HMGA1 expression in breast cancer reveals a positive correlation with tumour grade. Histol Histopathol 18:999-1004. DOI
Gross KL, Neskey D, Manchanda N, Weremowicz S, Kleinman MS, Nowak RA, Ligon AH, Rogalla P, Drechsler K, Bullerdiek J, Morton CC (2003). HMGA2 expression in uterine leiomyomata and myometrium: Quantitative analysis and tissue culture studies. Genes Chromosomes Cancer 38:68-79. DOI
Kayser K, Dunnwald D, Kazmierczak B, Bullerdiek J, Kaltner H, Zick Y, Andre S, Gabius HJ (2003). Chromosomal aberrations, profiles of expression of growth-related markers including galectins and environmental hazards in relation to the incidence of chondroid pulmonary hamartomas. Pathol Res Pract 199:589-598. DOI
Liehr T, Ziegler M, Starke H, Heller A, Kuechler A, Kittner G, Beensen V, Seidel J, Hässler H, Müsebeck J, Claussen (2003). Conspicuous GTG-banding results of the centromere-near region can be caused by alphoid DNA heteromorphism. Clin Genet 64:166-167. DOI
Meiboom M, Belge G, Bol S, El-Aouni C, Schoenmakers EF, Bullerdiek J (2003). Does conventional cytogenetics detect the real frequency of 19q13 aberrations in benign thyroid lesions? A survey of 38 cases. Cancer Genet Cytogenet 146:70-72. DOI
Meiboom M, Murua Escobar H, Pentimalli F, Fusco A, Belge G, Bullerdiek J (2003). A 3.4-kbp transcript of ZNF331 is solely expressed in follicular thyroid adenomas. Cytogenet Genome Res 101:113-117. DOI
Murua Escobar H, Meyer B, Richter A, Becker K, Flohr AM, Bullerdiek J, Nolte I (2003). Molecular characterization of the canine HMGB1. Cytogenet Genome Res 101:33-38. DOI
Rippe V, Drieschner N, Meiboom M, Murua Escobar H, Bonk U, Belge G, Bullerdiek J (2003). Identification of a gene rearranged by 2p21 aberrations in thyroid adenomas. Oncogene 22:6111-6114. DOI
Schlueter C, Hauke S, Flohr AM, Rogalla P, Bullerdiek J (2003). Tissue specific expression patterns of the RAGE receptor and its soluble forms - a result of regulated alternative splicing? Biochim Biophys Acta 1630:1-6. DOI

2002

Bullerdiek J (2002). Tumorzytogenetische und molekulargenetische Befunde bei soliden benignen Tumoren. Med Genet 14:135-138.
Hauke S, Flohr AM, Rogalla P, Bullerdiek J (2002). Sequencing of intron 3 of HMGIC reveals the existence of a novel exon of that gene. Genes Chromosomes Cancer 34:17-23. DOI
Lemke I, Rogalla P, Grundmann F, Kunze W-P, Haupt R, Bullerdiek J (2002). Expression of the HMGA2-LPP fusion transcript in only 1 of 61 karyotypically normal pulmonary chondroid hamartomas. Cancer Genet Cytogenet 138:160-164. DOI
Rogalla P, Lemke I, Bullerdiek J (2002). Absence of the HMGIC-LHFP fusion in pulmonary chondroid hamartomas with aberrations involving chromosomal regions 12q13-15 and 13q12-14. Cancer Genet Cytogenet 133:90-93. DOI
Rogalla P, Helbig R, Drieschner N, Krohn M, Bullerdiek J (2002). Molecular-cytogenetic analysis of fragmentation of chromosome 17 in the breast cancer cell line EFM-19. Anticancer Res 22:1987-1992.
Röijer E, Nordkvist A, Ström AK, Ryd W, Behrendt M, Bullerdiek J, Mark J, Stenman G (2002). Translocation, deletion/amplification, and expression of HMGIC and MDM2 in a carcinoma ex pleomorphic adenoma. Am J Pathol 160:433-440. DOI
Vockerodt M, Belge G, Kube D, Irsch J, Siebert R, Tesch H, Diehl V, Wolf J, Bullerdiek J, Staratschek-Jox A (2002). An unbalanced translocation involving chromosome 14 is the probable cause for loss of potentially functional rearranged immunoglobulin heavy chain genes in the Epstein-Barr virus-positive Hodgkin's lymphoma-derived cell line L591. Brit J Haematol 119:640-646. DOI

2001

Belge G, Rippe V, Meiboom M, Drieschner N, Garcia E, Bullerdiek J (2001). Delineation of a 150-kb breakpoint cluster in benign thyroid tumors with 19q13.4 aberrations. Cytogenet Cell Genet 93:48-51. DOI
Blank C, Schoenmakers, EFPM, Rogalla P, Huys ELPG., Van Rijk AAF, Drieschner N, Bullerdiek, J (2001). Intragenic breakpoint within Rad51L1 in a t(6;14)(p21.3;q24) of a pulmonary chondroid hamartoma. Cytogenet Cell Genet 95:17-19. DOI
Bol S, Belge G, Rippe V, Bullerdiek J (2001). Molecular cytogenetic investigations define a subgroup of thyroid adenomas with 2p21 breakpoints clustered to a region of less than 450 kb. Cytogenet Cell Genet 95:189-191. DOI
Bol S, Belge G, Thode B, Bonk U, Bartnitzke S, Bullerdiek J (2001). Cytogenetic tetraclonality in a rare spindle cell variant of an anaplastic carcinoma of the thyroid. Cancer Genet Cytogenet 125:1663-16. DOI
Borrmann L, Kim I, Schultheiss D, Rogalla P, Bullerdiek J (2001). Regulation of the expression of HMG1, a co-activator of the estrogen receptor. Anticancer Res 21:301-305.
Borrmann L, Wilkening S, Bullerdiek J (2001). The expression of HMGA genes is regulated by their 3'UTR. Oncogene 20:4537-4541. DOI
Flohr A M, Rogalla P, Meiboom M, Borrmann L, Krohn M, Thode-Halle B, Bullerdiek J (2001). Variation of HMGB1 expression in breast cancer. Anticancer Res 21:3881-3885.
Hauke S, Rippe V, Bullerdiek J (2001). Chromosomal rearrangements leading to abnormal splicing within intron 4 of HMGIC? Genes Chromosomes Cancer 30:302-304. DOI
Lemke I, Rogalla P, Bullerdiek J (2001). A novel LPP fusion gene indicates the crucial role of truncated LPP proteins in lipomas and pulmonary chondroid hamartomas. Cytogenet Cell Genet 95:153-156. DOI
Lemke I, Rogalla P, Bullerdiek J (2001). Large deletion of part of the HMGIC locus accompanying a t(3;12)(q27-q28;q14-q15) in a lipoma. Cancer Genet Cytogenet 129:161-164. DOI
Murua Escobar H, Becker K, Bullerdiek J, Nolte I (2001). The canine ERBB2 gene maps to a chromosomal region frequently affected by aberrations in tumors of the dog (Canis familiaris). Cytogenet Cell Genet 94: 194-195. DOI
Piekielko A, Drung A, Rogalla P, Schwanbeck R, Heyduk T, Gerharz M, Bullerdiek J, Wisniewski JR (2001). Distinct organization of DNA complexes of various HMGI/Y family proteins and their modulation upon mitotic phosphorylation. J Biol Chem 276:1984-1992. DOI
Rogalla P, Blank C, Helbig R, Wosniok W, Bullerdiek J (2001). Significant correlation between the breakpoints of rare clonal aberrations in benign solid tumors and the assignment of HMGIY retropseudogenes. Cancer Genet Cytogenet 130:51-56. DOI
Staratschek-Jox A, Thomas RK, Zander T, Massoudi N, Kornacker M, Bullerdiek J, Fonatsch C, Diehl V, Wolf J (2001). Loss of heterozygosity in the Hodgkin-Reed Sternberg cell line L1236. Br J Cancer 84:381-387. DOI

2000

Behrends S, Vehse K, Scholz H, Bullerdiek J, Kazmierczak B (2000). Assignment of GUCY1A3, a candidate gene for hypertension, to human chromosome bands 4q31.1-->q31.2 by in situ hybridization. Cytogenet Cell Genet 88:204-205. DOI
Blank C, Rogalla P, Tran KH, Bullerdiek J (2000). A novel high mobility group protein gene is a candidate for Xp22 abnormalities in uterine leiomyomas and other benign tumors. Cancer Genet Cytogenet 121:172-180. DOI
Hennig Y, Löschke S, Katenkamp D, Bartnitzke S, Bullerdiek J (2000). A malignant triton tumor with an unbalanced translocation (1;13)(q10;q10) and an isochromosome (8)(q10) as the sole karyotypic abnormalities. Cancer Genet Cytogenet 118:80-82. DOI
Kazmierczak B, Dal Cin P, Rogalla P, Van den Berghe H, Bullerdiek J (2000). Regional fine mapping of HMG17 to chromosomal band 1p35. Cancer Genet Cytogenet 116:164-165. DOI
Rogalla P, Kazmierczak B, Flohr AM, Hauke S, Bullerdiek J (2000). Back to the roots of a new exon--the molecular archaeology of a SP100 splice variant. Genomics 63:117-122. DOI
Rogalla P, Lemke I, Kazmierczak B, Bullerdiek J (2000). An identical HMGIC-LPP fusion transcript is consistently expressed in pulmonary chondroid hamartomas with t(3;12)(q27-28;q14-15). Genes Chromosomes Cancer 29:363-366. DOI
Santulli B, Kazmierczak B, Napolitano R, Caliendo I, Chiappetta G, Rippe V, Bullerdiek J , Fusco A (2000). A 12q13 translocation involving the HMGI-C gene in richter transformation of a chronic lymphocytic leukemia. Cancer Genet Cytogenet 119:70-73. DOI
Schwanbeck R, Gerharz M, Drung A, Rogalla P, Piekielko A, Blank C, Bullerdiek J, Wisniewski J (2000). Point mutations within AT-hook domains of the HMGI homologue HMGIYL1 affect binding to gene promoter but not to four-way junction DNA. Biochemistry 39:14419-14425. DOI
Spranger S, Rommel B, Jauch A, Bodammer R, Mehl B, Bullerdiek J (2000). Interstitial deletion of 5q33.3q35.1 in a girl with mild mental retardation. Am J Med Genet 93:107-109. DOI
Staratschek-Jox A, Bullerdiek J (2000). Chromosomal Aberrations and Molecular Changes in Therapy-Related Leukemia. in: Rüther U, Nunnensiek C, Schmoll H-J (eds): Secondary Neoplasias following Chemotherapy, Radiotherapy, and Immunosuppression. Contrib Oncol. Basel, Karger, 2000, vol 55, pp 139-146. DOI
Staratschek-Jox A, Kotkowski S, Belge G, Rüdiger T, Bullerdiek J, Diehl V, Wolf J (2000). Detection of Epstein-Barr virus in Hodgkin-Reed-Sternberg cells : no evidence for the persistence of integrated viral fragments in latent membrane protein-1 (LMP-1)-negative classical Hodgkin's disease. Am J Pathol 156:209-216. DOI
Tallini G, Vanni R, Manfioletti G, Kazmierczak B, Faa G, Pauwels P, Bullerdiek J, Giancotti V, Van den Berghe H, Dal Cin P (2000). HMGI-C and HMGI(Y) immunoreactivity correlates with cytogenetic abnormalities in lipomas, pulmonary chondroid hamartomas, endometrial polyps, and uterine leiomyomas and is compatible with rearrangement of the HMGI-C and HMGI(Y) genes. Lab Invest 80:359-369. DOI

1999

Behrends S, Kazmierczak B, Steenpass A, Knauf B, Bullerdiek J, Scholz H, Eiberg H (1999). Assignment of GUCY1B2, the gene coding for the beta2 subunit of human guanylyl cyclase to chromosomal band 13q14.3 between markers D13S168 and D13S155. Genomics 55:126-127. DOI
Bol S, Belge G, Thode B, Bartnitzke S, Bullerdiek J (1999). Structural abnormalities of chromosome 2 in benign thyroid tumors. Three new cases and review of the literature. Cancer Genet Cytogenet 114:75-77. DOI
Breen M, Bullerdiek J, Langford CF (1999). The DAPI banded karyotype of the domestic dog (Canis familiaris) generated using chromosome-specific paint probes. Chromosome Res 7:401-406. DOI
Bullerdiek J, Rommel B (1999). Diagnostic and molecular implications of specific chromosomal translocations in mesenchymal tumors. Histol Histopathol 14:1165-1173. DOI
Bullerdiek J (1999). Leiomyoma--do viruses play the main role? Genes Chromosomes Cancer 26:181. DOI
Dal Cin P, Fusco A, Belge G, Chiappetta G, Fedele M, Pauwels P, Bullerdiek J, Van den Berghe H (1999). Involvement of the HMGI(Y) gene in a microfollicular adenoma of the thyroid. Genes Chromosomes Cancer 24:286-289. DOI
Hennig Y, Caselitz J, Stern C, Bartnitzke S, Bullerdiek J (1999). Karyotype evolution in a case of uterine angioleiomyoma. Cancer Genet Cytogenet 108:79-80. DOI
Hennig Y, Deichert U, Bonk U, Thode B, Bartnitzke S, Bullerdiek J (1999). Chromosomal translocations affecting 12q14-15 but not deletions of the long arm of chromosome 7 associated with a growth advantage of uterine smooth muscle cells. Mol Hum Reprod 5:1150-1154. DOI
Hörsting N, Wohlsein P, Reimann N, Bartnitzke S, Bullerdiek J, Nolte I (1999). Cytogenetic analysis of three oropharyngeal malignant melanomas in dogs. Res Vet Sci 67:149-151. DOI
Kazmierczak B, Borrmann L, Bullerdiek J (1999). Assignment of a new gene (LBH). Genomics 56:136-137. DOI
Kazmierczak B, Dal Cin P, Meyer-Bolte K, Van den Berghe H, Bullerdiek J (1999). HMG1 is not rearranged by 13q12 aberrations in lipomas. Genes Chromosomes Cancer 24:290-292. DOI
Kazmierczak B, Dal Cin P, Sciot R, Van den Berghe H, Bullerdiek J (1999). Inflammatory myofibroblastic tumor with HMGIC rearrangement. Cancer Genet Cytogenet 112:156-160. DOI
Kazmierczak B, Kayser K, Meyer-Bolte K, Thode E, Bullerdiek J (1999). Results of cytogenetic analyses on 317 pulmonary chondroid hamartomas point to their pathogenesis. E J Pathol 5(4).
Kazmierczak B, Meyer-Bolte K, Tran KH, Wöckel W, Breightman I, Rosigkeit J, Bartnitzke S, Bullerdiek J (1999). A high frequency of tumors with rearrangements of genes of the HMGI(Y) family in a series of 191 pulmonary chondroid hamartomas. Genes Chromosomes Cancer 26:125-133. DOI
Polito P, Dal Cin P, Kazmierczak B, Rogalla P, Bullerdiek J, Van den Berghe H (1999). Deletion of HMG17 in uterine leiomyomas with ring chromosome 1. Cancer Genet Cytogenet 108:107-109. DOI
Reimann N, Bartnitzke S, Nolte I, Bullerdiek J (1999). Working with canine chromosomes: current recommendations for karyotype description. J Hered 90:31-34. DOI
Reimann N, Nolte I, Bartnitzke S, Bullerdiek J (1999). Re: Sit, DNA, sit: cancer genetics going to the dogs. J Natl Cancer Inst 91:1688-1689. DOI
Reimann N, Nolte I, Bonk U, Bartnitzke S, Bullerdiek J (1999). Cytogenetic investigation of canine lipomas. Cancer Genet Cytogenet 111:172-174. DOI
Rippe V, Belge G, Meiboom M, Kazmierczak B, Fusco A, Bullerdiek J (1999). A KRAB zinc finger protein gene is the potential target of 19q13 translocation in benign thyroid tumors. Genes Chromosomes Cancer 26:229-236. DOI
Rohen C, Rogalla P, Meyer-Bolte K, Bartnitzke S, Chilla R, Bullerdiek J (1999). Pleomorphic adenomas of the salivary glands: absence of HMGIY rearrangements. Cancer Genet Cytogenet 111:178-181. DOI

1998

Belge G, Roque L, Soares J, Bruckmann S, Thode B, Fonseca E, Clode A, Bartnitzke S, Castedo S, Bullerdiek J (1998). Cytogenetic investigations of 340 thyroid hyperplasias and adenomas revealing correlations between cytogenetic findings and histology. Cancer Genet Cytogenet 101:42-48. DOI
Belge G, Roque L, Thode B, Fonseca E, Soares J, Clode A, Bartnitzke S, Castedo S, Bullerdiek J (1997). Zytogenetische Veränderungen bei benignen Schilddrüsenhyperplasien und Adenomen korrelieren mit der Histologie. Verh Dtsch Ges Pathol 81:151-156.
Dal Cin P, Timmerman D, Van den Berghe I, Wanschura S, Kazmierczak B, Vergote I, Deprest J, Neven P, Moerman P, Bullerdiek J, Van den Berghe H (1998). Genomic changes in endometrial polyps associated with tamoxifen show no evidence for its action as an external carcinogen. Cancer Res 58:2278-2281.
Dal Cin P, Wanschura S, Kazmierczak B, Tallini G, Dei Tos A, Bullerdiek J, Van den Berghe I, Moerman P, Van den Berghe H (1998). Amplification and expression of the HMGIC gene in a benign endometrial polyp. Genes Chromosomes Cancer 22:95-99. DOI
Fedele M, Berlingieri MT, Scala S, Chiariotti L, Viglietto G, Rippe V, Bullerdiek J, Santoro M, Fusco A (1998). Truncated and chimeric HMGI-C genes induce neoplastic transformation of NIH3T3 murine fibroblasts. Oncogene 17:413-418. DOI
Hirning-Folz U, Wilda M, Rippe V, Bullerdiek J, Hameister H (1998). The expression pattern of the Hmgic gene during development. Genes Chromosomes Cancer 23:350-357. DOI
Hörsting N, von Reiswitz A, Wohlsein P, Bullerdiek J, Reimann N, Nolte I (1998). Oropharyngeale Tumoren des Hundes - eine klinische Studie über 79 Fälle. Berl Münch Tierarztl Wochenschr 111:242-247.
Jox A, Taquia E, Vockerodt M, Draube A, Pawlita M, Möller P, Bullerdiek J, Diehl V, Wolf J (1998). Stable nontumorigenic phenotype of somatic cell hybrids between malignant Burkitt's lymphoma cells and autologous EBV-immortalized B cells despite induction of chromosomal breakage and loss. Cancer Res 58:4930-4939.
Kazmierczak B, Bullerdiek J, Pham KH, Bartnitzke S, Wiesner H (1998). Intron 3 of HMGIC is the most frequent target of chromosomal aberrations in human tumors and has been conserved basically for at least 30 million years. Cancer Genet Cytogenet 103:175-177. DOI
Kazmierczak B, Dal Cin P, Wanschura S, Bartnitzke S, Van den Berghe H, Bullerdiek J (1998). Cloning and molecular characterization of part of a new gene fused to HMGIC in mesenchymal tumors. Am J Pathol 152:431-435. PMCID
Kazmierczak B, Dal Cin P, Wanschura S, Borrmann L, Fusco A, Van den Berghe H, Bullerdiek J (1998). HMGIY is the target of 6p21.3 rearrangements in various benign mesenchymal tumors. Genes Chromosomes Cancer 23:279-285. DOI
Reimann N, Bartnitzke S, Bullerdiek J, Mischke R, Nolte I (1998). Trisomy 1 in a canine acute leukemia indicating the pathogenetic importance of polysomy 1 in leukemias of the dog. Cancer Genet Cytogenet 101:49-52. DOI
Rogalla P, Borda Z, Meyer-Bolte K, Tran KH, Hauke S, Nimzyk R, Bullerdiek J (1998). Mapping and molecular characterization of five HMG1-related DNA sequences. Cytogenet Cell Genet 83:124-129. DOI
Rogalla P, Drechsler K, Schröder-Babo W, Eberhardt K, Bullerdiek J (1998). HMGIC expression patterns in non-small lung cancer and surrounding tissue. Anticancer Res 18:3327-3330.
Rogalla P, Kazmierczak B, Meyer-Bolte K, Tran KH, Bullerdiek J (1998). The t(3;12)(q27;q14-q15) with underlying HMGIC-LPP fusion is not determining an adipocytic phenotype. Genes Chromosomes Cancer 22:100-104. DOI
Roque L, Clode A, Belge G, Pinto A, Bartnitzke S, Santos JR, Thode B, Bullerdiek J, Castedo S, Soares J (1998). Follicular thyroid carcinoma: chromosome analysis of 19 cases. Genes Chromosomes Cancer 21:250-255. DOI
Staats B, Bonk U, Gohla G, Bartnitzke S, Bullerdiek J (1998). Two cases of fibrocystic breast disease with polysomy 18 as the sole clonal cytogenetic abnormality. Cancer Genet Cytogenet 103:91-94. DOI

1997

Belge G, Caselitz J, Bonk U, Bartnitzke S, Bullerdiek J (1997). Genetische Untersuchungen zur Differentialdiagnose von Fettgewebstumoren. Pathologe 18:160-166. DOI
Belge G, Garcia E, Rippe V, Fusco A, Bartnitzke S, Bullerdiek J (1997). Breakpoints of 19q13 translocations of benign thyroid tumors map within a 400 kilobase region. Genes Chromosomes Cancer 20:201-203. DOI
Belge G, Roque L, Thode B, Fonseca E, Soares J, Clode A, Bartnitzke S, Castedo S, Bullerdiek J (1997). Zytogenetische Veränderungen bei benignen Schilddrüsenhyperplasien und Adenomen korrelieren mit der Histologie. Verh. Dtsch. Ges. Pathol. 81: 151-156.
Dal Cin P, Wanschura S, Christiaens MR, Van den Berghe I, Moerman P, Polito P, Kazmierczak B, Bullerdiek J, Van Den Berghe H (1997). Hamartoma of the breast with involvement of 6p21 and rearrangement of HMGIY. Genes Chromosomes Cancer 20:90-92. DOI
Hennig Y, Caselitz J, Bartnitzke S, Bullerdiek J (1997). A third case of a low-grade endometrial stromal sarcoma with a t(7;17)(p14 -21;q11.2-21). Cancer Genet Cytogenet 98:84-86. DOI
Hennig Y, Rogalla P, Wanschura S, Frey G, Deichert U , Bartnitzke S, Bullerdiek J (1997). HMGIC expressed in a uterine leiomyoma with a deletion of the long arm of chromosome 7 along with a 12q14-15 rearrangement but not in tumors showing del(7) as the sole cytogenetic abnormality. Cancer Genet Cytogenet 96:129-133. DOI
Jox A, Rohen C, Belge G, Bartnitzke S, Pawlita M, Diehl V, Bullerdiek J, Wolf J (1997). Integration of Epstein-Barr virus in Burkitt's lymphoma cells leads to a region of enhanced chromosome instability. Ann Oncol 8 Suppl 2:131-135. DOI
Nolte I, Reimann N, Bullerdiek J, Bartnitzke S, Mischke R, Nolte M (1997). Die Bedeutung zytogenetischer Untersuchungen bei Leukämien des Hundes. Tierarztl Prax 25:393-397.
Rogalla P, Drechsler K, Kazmierczak B, Rippe V, Bonk U, Bullerdiek J (1997). Expression of HMGI-C, a member of the high mobility group protein family, in a subset of breast cancers: relationship to histologic grade. Mol Carcinog 19:153-156. DOI
Rommel B, Rogalla P, Jox A, Kalle CV, Kazmierczak B, Wolf J, Bullerdiek J (1997). HMGI-C, a member of the high mobility group family of proteins, is expressed in hematopoietic stem cells and in leukemic cells. Leuk Lymphoma 26:603-607. DOI
Vanni R, Marras S, Schoenmakers EF, Dal Cin P, Kazmierczak B, Senger G, Bullerdiek J, Van de Ven WJ, Van Den Berghe H (1997). Molecular cytogenetic characterization of del(7q) in two uterine leiomyoma-derived cell lines. Genes Chromosomes Cancer 18:155-161. DOI
Wanschura S, Dal Cin P, Kazmierczak B, Bartnitzke S, Van den Berghe H, Bullerdiek J (1997). Hidden paracentric inversions of chromosome arm 12q affecting the HMGIC gene. Genes Chromosomes Cancer 18:322-323. DOI
Wanschura S, Kazmierczak B, Bonk U, Bartnitzke S, Bullerdiek J (1997). Rearrangierungen des HMGIC Gens in benignen mesenchymalen Tumoren mit Veränderungen der chromosomalen Region 12q14-15. Verh Dtsch Ges Path 81:607.

1996

Belge G, Bruckmann S, Thode B, Bartnitzke S, Bullerdiek J (1996). Deletions of the short arm of chromosome 2 characterize a new cytogenetic subgroup of benign thyroid tumors. Genes Chromosomes Cancer 16:149-151. DOI
Bol S, Wanschura S, Thode B, Deichert U, Van de Ven WJ, Bartnitzke S, Bullerdiek J (1996). An endometrial polyp with a rearrangement of HMGI-C underlying a complex cytogenetic rearrangement involving chromosomes 2 and 12. Cancer Genet Cytogenet 90:88-90. DOI
Hennig Y, Deichert U, Stern C, Ghassemi A, Thode B, Bonk U, Meister P, Bartnitzke S, Bullerdiek J (1996). Structural aberrations of chromosome 6 in three uterine smooth muscle tumors. Cancer Genet Cytogenet 87:148-151. DOI
Hennig Y, Wanschura S, Deichert U, Bartnitzke S, Bullerdiek J (1996). Rearrangements of the high mobility group protein family genes and the molecular genetic origin of uterine leiomyomas and endometrial polyps. Mol Hum Reprod 2:277-283. DOI
Kazmierczak B, Bol S, Wanschura S, Bartnitzke S, Bullerdiek J (1996). PAC clone containing the HMGI(Y) gene spans the breakpoint of a 6p21 translocation in a uterine leiomyoma cell line. Genes Chromosomes Cancer 17:191-193. DOI
Kazmierczak B, Pohnke Y, Bullerdiek J (1996). Fusion transcripts between the HMGIC gene and RTVL-H-related sequences in mesenchymal tumors without cytogenetic aberrations. Genomics 38:223-226. DOI
Kazmierczak B, Rosigkeit J, Wanschura S, Meyer-Bolte K, Van de Ven WJ, Kayser K, Krieghoff B, Kastendiek H, Bartnitzke S, Bullerdiek J (1996). HMGI-C rearrangements as the molecular basis for the majority of pulmonary chondroid hamartomas: a survey of 30 tumors. Oncogene 12:515-521.
Kazmierczak B, Wanschura S, Rommel B, Bartnitzke S, Bullerdiek J (1996). Ten pulmonary chondroid hamartomas with chromosome 6p21 breakpoints within the HMG-I(Y) gene or its immediate surroundings. J Natl Cancer Inst 88:1234-1236. DOI
Leuschner E, Staats B, Gohla G, Bartnitzke S, Bonk U, Bullerdiek J (1996). Fluorescence in situ hybridization studies on breast tumor samples for distinguishing between different subsets of breast cancer. Acta Cytol 40:151-157. DOI
Reimann N, Bartnitzke S, Bullerdiek J, Schmitz U, Rogalla P, Nolte I, Ronne M (1996). An extended nomenclature of the canine karyotype. Cytogenet Cell Genet 73:140-144. DOI
Reimann N, Nolte I, Bonk U, Werner M, Bullerdiek J, Bartnitzke S (1996). Trisomy 18 in a canine thyroid adenoma. Cancer Genet Cytogenet 90:154-156. DOI
Rogalla P, Drechsler K, Frey G, Hennig Y, Helmke B, Bonk U, Bullerdiek J (1996). HMGI-C expression patterns in human tissues. Implications for the genesis of frequent mesenchymal tumors. Am J Pathol 149:775-779. PMCID
Rogalla P, Rohen C, Bonk U, Bullerdiek J (1996). Telomeric repeat fragment lengths are not correlated to histological grading in 85 breast cancers. Cancer Lett 106:155-161. DOI
Rohen C, Staats B, Bonk U, Bartnitzke S, Bullerdiek J (1996). Significance of clonal chromosome aberrations in breast fibroadenomas. Cancer Genet Cytogenet 87:152-155. DOI
Rohen G, Bartnitzke S, Bullerdiek J, Bonk U (1996). Trisomy 8 and 20 in desmoid tumors and breast cancer: more than a casual coincidence? Cancer Genet Cytogenet 86:92. DOI
Röijer E, Kas K, Klawitz I, Bullerdiek J, Van de Ven W, Stenman G (1996). Identification of a yeast artificial chromosome spanning the 8q12 translocation breakpoint in pleomorphic adenomas with t(3;8)(p21;q12). Genes Chromosomes Cancer 17:166-171. DOI
Staats B, Bonk U, Wanschura S, Hanisch P, Schoenmakers EF, Van de Ven WJ, Bartnitzke S, Bullerdiek J (1996). A fibroadenoma with a t(4;12) (q27;q15) affecting the HMGI-C gene, a member of the high mobility group protein gene family. Breast Cancer Res Treat 38:299-303. DOI
Wanschura S, Belge G, Stenman G, Kools P, Dal Cin P, Schoenmakers E, Huysmans C, Van den Berghe H, Bartnitzke S, Van de Ven WJ, Bullerdiek J (1996). Mapping of the translocation breakpoints of primary pleomorphic adenomas and lipomas within a common region of chromosome 12. Cancer Genet Cytogenet 86:39-45. DOI
Wanschura S, Kazmierczak B, Bartnitzke S, Bullerdiek J, Schloot W, Schoenmakers E, Meyen E, Van de Ven W (1996). Molecular cytogenetic assignment of the chromosome 12 breakpoints in many benign tumors to 12q15 affecting the HMGIC gene. Genes Chromosomes Cancer 15:195-196. DOI
Wanschura S, Kazmierczak B, Pohnke Y, Meyer-Bolte K, Bartnitzke S, Van de Ven WJ, Bullerdiek J (1996). Transcriptional activation of HMGI-C in three pulmonary hamartomas each with a der(14)t(12;14) as the sole cytogenetic abnormality. Cancer Lett 102:17-21. DOI
Wanschura S, Schoenmakers EF, Huysmans C, Bartnitzke S, Van de Ven WJ, Bullerdiek J (1996). Mapping of the gene encoding the human hepatoma-derived growth factor (HDGF) with homology to the high-mobility group (HMG)-1 protein to Xq25. Genomics 32:298-300. DOI
Wanschura S, Schoenmakers EFPM, Huysmans C, Bartnitzke S, Van de Ven WJM, Bullerdiek J (1996). Mapping of the human HMG2 gene to 4q31. Genomics 31:264-265. DOI

1995

Belge G, Garcia E, de Jong P, Bartnitzke S, Bullerdiek J (1995). FISH analyses of a newly established thyroid tumor cell line showing a t(1;19)(p35 or p36.1;q13) reveal that the breakpoint lies between 19q13.3-13.4 and 19q13.4. Cytogenet Cell Genet 69:220-222. DOI
Dürst M, Seagon S, Wanschura S, zur Hausen H, Bullerdiek J (1995). Malignant progression of an HPV16-immortalized human keratinocyte cell line (HPKIA) in vitro. Cancer Genet Cytogenet 85:105-112. DOI
Kazmierczak B, Hennig Y, Wanschura S, Rogalla P, Bartnitzke S, Van de Ven W, Bullerdiek J (1995). Description of a novel fusion transcript between HMGI-C, a gene encoding for a member of the high mobility group proteins, and the mitochondrial aldehyde dehydrogenase gene. Cancer Res 55:6038-6039.
Kazmierczak B, Stern C, Bartnitzke S, Bullerdiek J (1995). Non-random jumping translocations as a result of SV40 large T-antigen expression in benign human tumor cells. Cell Biol Int 19:315-322. DOI
Kazmierczak B, Wanschura S, Meyer-Bolte K, Caselitz J, Meister P, Bartnitzke S, Van de Ven W, Bullerdiek J (1995). Cytogenic and molecular analysis of an aggressive angiomyxoma. Am J Pathol 147:580-585.
Kazmierczak B, Wanschura S, Rosigkeit J, Meyer-Bolte K, Uschinsky K, Haupt R, Schoenmakers EF, Bartnitzke S, Van de Ven WJ, Bullerdiek J (1995). Molecular characterization of 12q14-15 rearrangements in three pulmonary chondroid hamartomas. Cancer Res 55:2497-2499.
Kools PF, Wanschura S, Schoenmakers EF, Geurts JM, Mols R, Kazmierczak B, Bullerdiek J, Van den Berghe H, Van de Ven WJ (1995). Identification of the chromosome 12 translocation breakpoint region of a pleomorphic salivary gland adenoma with t(1;12)(p22;q15) as the sole cytogenetic abnormality. Cancer Genet Cytogenet 79:1-7. DOI
Rogalla P, Rohen C, Hennig Y, Deichert U, Bonk U, Bullerdiek J (1995). Telomere repeat fragment sizes do not limit the growth potential of uterine leiomyomas. Biochem Biophys Res Commun 211:175-182. DOI
Rohen C, Caselitz J, Stern C, Wanschura S, Schoenmakers EF, Van de Ven WJ, Bartnitzke S, Bullerdiek J (1995). A hamartoma of the breast with an aberration of 12q mapped to the MAR region by fluorescence in situ hybridization. Cancer Genet Cytogenet 84:82-84. DOI
Rohen C, Meyer-Bolte K, Bonk U, Ebel T, Staats B, Leuschner E, Gohla G, Caselitz J, Bartnitzke S, Bullerdiek J (1995). Trisomy 8 and 18 as frequent clonal and single-cell aberrations in 185 primary breast carcinomas. Cancer Genet Cytogenet 80:33-39. DOI
Schoenmakers EF, Geurts JM, Kools PF, Mols R, Huysmans C, Bullerdiek J, Van den Berghe H, Van de Ven WJ (1995). A 6-Mb yeast artificial chromosome contig and long-range physical map encompassing the region on chromosome 12q15 frequently rearranged in a variety of benign solid tumors. Genomics 29:665-678. DOI
Schoenmakers EF, Wanschura S, Mols R, Bullerdiek J, Van den Berghe H, Van de Ven WJ (1995). Recurrent rearrangements in the high mobility group protein gene, HMGI-C, in benign mesenchymal tumours. Nat Genet 10:436-444. DOI
Van de Ven WJ, Schoenmakers EF, Wanschura S, Kazmierczak B, Kools PF, Geurts JM, Bartnitzke S, Van den Berghe H, Bullerdiek J (1995). Molecular characterization of MAR, a multiple aberration region on human chromosome segment 12q13-q15 implicated in various solid tumors. Genes Chromosomes Cancer 12:296-303. DOI
Wanschura S, Hennig Y, Deichert U, Schoenmakers EF, Van de Ven WJ, Bartnitzke S, Bullerdiek J (1995). Molecular-cytogenetic refinement of the 12q14-->q15 breakpoint region affected in uterine leiomyomas. Cytogenet Cell Genet 71:131-135. DOI
Wanschura S, Kazmierczak B, Schoenmakers E, Meyen E, Bartnitzke S, Van de Ven W, Bullerdiek J, Schloot W (1995). Regional fine mapping of the multiple-aberration region involved in uterine leiomyoma, lipoma, and pleomorphic adenoma of the salivary gland to 12q15. Genes Chromosomes Cancer 14:68-70. DOI
Wolf J, Jox A, Skarbek H, Pukrop T, Bartnitzke S, Pawlita M, Diehl V, Bullerdiek J (1995). Selective loss of integrated Epstein-Barr virus genomes after long-term cultivation of Burkitt's lymphoma x B-lymphoblastoid cell hybrids due to chromatin instability at the integration site. Virology 212:179-185. DOI

1994

Belge G, Thode B, Bartnitzke S, Bullerdiek J (1994). Cytogenetic biclonality corresponding to multiphasic differentiation in an atypical thyroid adenoma. Cancer Genet Cytogenet 78:102-104. DOI
Belge G, Thode B, Rippe V, Bartnitzke S, Bullerdiek J (1994). A characteristic sequence of trisomies starting with trisomy 7 in benign thyroid tumors. Hum Genet 94:198-202. DOI
Bullerdiek J, Bonk U, Staats B, Leuschner E, Gohla G , Ebel T, Bartnitzke S (1994). Trisomy 18 as the first chromosome abnormality in a medullary breast cancer. Cancer Genet Cytogenet 73:75-78. DOI
Franke S, Klawitz I, Schnakenberg E, Rommel B, Van de Ven W, Bullerdiek J, Schloot W (1994). Isolation and mapping of a cosmid clone containing the human NAT2 gene. Biochem Biophys Res Commun 199:52-55. DOI
Kapp U, Dux A, Schell-Frederick E, Banik N, Hummel M , Mucke S, Fonatsch C, Bullerdiek J, Gottstein C, Engert A, Diehl V, Wolf J (1994). Disseminated growth of Hodgkin's-derived cell lines L540 and L540cy in immune-deficient SCID mice. Ann Oncol 5 Suppl 1:121-126. DOI
Kools PF, Roebroek AJ, Van de Velde HJ, Marynen P, Bullerdiek J, Van de Ven WJ (1994). Regional mapping of the human NSP gene to chromosome region 14q21-->q22 by fluorescence in situ hybridization analysis. Cytogenet Cell Genet 66:48-50. DOI
Leuschner E, Meyer-Bolte K, Caselitz J, Bartnitzke S, Bullerdiek J (1994). Fibroadenoma of the breast showing a translocation (6;14), a ring chromosome and two markers involving parts of chromosome 11. Cancer Genet Cytogenet 76:145-147. DOI
Reimann N, Rogalla P, Kazmierczak B, Bonk U, Nolte I , Grzonka T, Bartnitzke S, Bullerdiek J (1994). Evidence that metacentric and submetacentric chromosomes in canine tumors can result from telomeric fusions. Cytogenet Cell Genet 67:81-85. DOI
Rogalla P, Kazmierczak B, Rohen C, Trams G, Bartnitzke S, Bullerdiek J (1994). Two human breast cancer cell lines showing decreasing telomeric repeat length during early in vitro passaging. Cancer Genet Cytogenet 77:19-25. DOI
Schoenmakers EF, Kools PF, Mols R, Kazmierczak B, Bartnitzke S, Bullerdiek J, Dal Cin P, De Jong PJ, Van den Berghe H, Van de Ven WJ (1994). Physical mapping of chromosome 12q breakpoints in lipoma, pleomorphic salivary gland adenoma, uterine leiomyoma, and myxoid liposarcoma. Genomics 20:210-222. DOI
Schoenmakers EF, Mols R, Wanschura S, Kools PF, Geurts JM, Bartnitzke S, Bullerdiek J, Van den Berghe H, Van de Ven WJ (1994). Identification, molecular cloning, and characterization of the chromosome 12 breakpoint cluster region of uterine leiomyomas. Genes Chromosomes Cancer 11:106-118. DOI

1993

Bullerdiek J, Leuschner E, Taquia E, Bonk U, Bartnitzke S (1993). Trisomy 8 as a recurrent clonal abnormality in breast cancer? Cancer Genet Cytogenet 65:64-67. DOI
Bullerdiek J, Wobst G, Meyer-Bolte K, Chilla R, Haubrich J, Thode B, Bartnitzke S (1993). Cytogenetic subtyping of 220 salivary gland pleomorphic adenomas: correlation to occurrence, histological subtype, and in vitro cellular behavior. Cancer Genet Cytogenet 65:27-31. DOI
Delecluse HJ, Bartnizke S, Hammerschmidt W, Bullerdiek J, Bornkamm GW (1993). Episomal and integrated copies of Epstein-Barr virus coexist in Burkitt lymphoma cell lines. J Virol 67:1292-1299.DOI
Lotz S, Caselitz J, Bullerdiek J, Rieckhoff KU (1993). Monophasisch fibröses Synovialsarkom der Hand mit biphasisch differenzierten Lungenmetastasen. Pathologe 14:54-57.
Rohen C, Bonk U, Staats B, Bartnitzke S, Bullerdiek J (1993). Two human breast tumors with translocations involving 12q13-15 as the sole cytogenetic abnormality. Cancer Genet Cytogenet 69:68-71. DOI
Schoenmakers HF, Kools PF, Kazmierczak B, Bullerdiek J, Claussen U, Horsthemke B, Van den Berghe H, Van de Ven WJ (1993). Isolation of a somatic cell hybrid retaining the der(16)t(12;16)(q13;p11.2) from a myxoid liposarcoma cell line. Cytogenet Cell Genet 62:159-161. DOI
Wolf J, Pawlita M, Jox A, Kohls S, Bartnitzke S, Diehl V, Bullerdiek J (1993). Integration of Epstein Barr virus near the breakpoint of a translocation 11;19 in a Burkitt's lymphoma cell line. Cancer Genet Cytogenet 67:90-94. DOI

1992

Bartnitzke S, Motzko H, Caselitz J, Kornberg M, Bullerdiek J, Schloot W (1992). A recurrent marker chromosome involving chromosome 1 in two mammary tumors of the dog. Cytogenet Cell Genet 60:135-137. DOI
Bartnitzke S, Motzko H, Rosenhagen C, Bullerdiek J (1992). Benign mixed tumor of canine mammary gland showing an r(X) and trisomy 5 as the only clonal abnormalities. Cancer Genet Cytogenet 62:29-31. DOI
Bartnitzke S, Skarbek H, Lackmann C, Bullerdiek J (1992). Chang medium raises the chromatin instability of pericentromeric areas of chromosome 1 in amniotic fluid cells. Prenat Diagn 12:310-311. DOI
Belge G, Kazmierczak B, Meyer-Bolte K, Bartnitzke S, Bullerdiek J (1992). Expression of SV40 T-antigen in lipoma cells with a chromosomal translocation t(3;12) is not sufficient for direct immortalization. Cell Biol Int Rep 16:339-347. DOI
Belge G, Thode B, Bullerdiek J, Bartnitzke S (1992). Aberrations of chromosome 19. Do they characterize a subtype of benign thyroid adenomas? Cancer Genet Cytogenet 60:23-26. DOI
Delecluse HJ, Kohls S, Bullerdiek J, Bornkamm GW (1992). Integration of EBV in Burkitt's lymphoma cells." Curr Top Microbiol Immunol 182:367-373. DOI
Kazmierczak B, Thode B, Bartnitzke S, Bullerdiek J, Schloot W (1992). Pleomorphic adenoma cells vary in their susceptibility to SV40 transformation depending on the initial karyotype. Genes Chromosomes Cancer 5:35-39. DOI
Stern C, Deichert U, Thode B, Bartnitzke S, Bullerdiek J (1992). Eine zytogenetische Subtypisierung von 139 Uterus-Leiomyomen. Geburtshilfe Frauenheilkd 52:767-772. DOI

1991

Belge G, Thode B, Bullerdiek J, Bartnitzke S (1991). Deletion of part of the long arm of chromosome 13 as the only karyotypic aberration in a follicular thyroid adenoma. Cancer Genet Cytogenet 56:277-280. DOI
Bullerdiek J, Bartnitzke S (1991). Chromosomal abnormalities in pleomorphic adenomas. Related to origin or karyotypic evolution? Cancer Genet Cytogenet 53:283-284. DOI
Chen G, Hutter KJ, Bullerdiek J, Zeller WJ (1991). Karyotypic change from heteroploidy to near diploidy associated with development of cisplatin resistance in a rat ovarian tumour cell line. J Cancer Res Clin Oncol 117:539-542. DOI
Rommel B, de Villiers EM, Durst M, Bartnitzke S, Bullerdiek J (1991). Failure to detect human papillomavirus sequences at the 3p21 rearrangement site in pleomorphic adenomas. Cancer Genet Cytogenet 52:187-191. DOI
Stern C, Kazmierczak B, Thode B, Rommel B, Bartnitzke S, Dal Cin P, Van de Ven, Van den Berghe H, Bullerdiek J (1991). Leiomyoma cells with 12q15 aberrations can be transformed in vitro and show a relatively stable karyotype during precrisis period. Cancer Genet Cytogenet 54:223-228. DOI

1990

Bartnitzke S, Eberhardt D, Krooss J, Rommel B, Bullerdiek J (1990). In situ nick translation of human chromosomes using Alu I: unmasking of recognition sites by proteinase K pretreatment. Cytobios 62:93-99.
Bullerdiek J, Hutter KJ, Brandt G, Weinberg M, Belge G, Bartnitzke S (1990). Cytogenetic investigations on a cell line derived from a carcinoma arising in a salivary gland pleomorphic adenoma. Cancer Genet Cytogenet 44:253-262. DOI
Bullerdiek J, Vollrath M, Wittekind C, Caselitz J, Bartnitzke S (1990). Mucoepidermoid tumor of the parotid gland showing a translocation (3;8)(p21;q12) and a deletion (5)(q22) as sole chromosome abnormalities. Cancer Genet Cytogenet 50:161-164. DOI
Kazmierczak B, Bartnitzke S, Hartl M, Bullerdiek J (1990). In vitro transformation by the SV40 'early region' of cells from a human benign salivary gland tumor with a 12q13→q15 rearrangement. Cytogenet Cell Genet 53:37-39. DOI
Rommel B, Bullerdiek J, Bartnitzke S, Schloot W (1990). No rearrangement of c-mos in salivary gland pleomorphic adenomas with 8q12 aberrations. Cancer Genet Cytogenet 49:165-169. DOI
Stern C, Meyer K, Bartnitzke S, Schloot W, Bullerdiek J (1990). Pleomorphic adenomas with unbalanced chromosomal abnormalities have an increased in vitro lifetime. Cancer Genet Cytogenet 46:55-63. DOI
Wolf J, Pawlita M, Bullerdiek J, zur Hausen H (1990). Suppression of the malignant phenotype in somatic cell hybrids between Burkitt's lymphoma cells and Epstein-Barr virus-immortalized lymphoblastoid cells despite deregulated c-myc expression. Cancer Res 50:3095-3100.
Wolf J, Pawlita M, Bullerdiek J, zur Hausen H (1990). Deregulated c-myc gene expression and persistence of EBV are not sufficient to maintain the malignant phenotype in Burkitt's lymphoma x B-lymphoblastoid hybrid cells. Curr Top Microbiol Immunol 166:333-336. DOI

1979 - 1989

Bartnitzke S, Herrmann ME, Lobeck H, Zuschneid W, Neuhaus P, Bullerdiek J (1989). Cytogenetic findings on eight follicular thyroid adenomas including one with a t(10;19). Cancer Genet Cytogenet 39:65-68. DOI
Bullerdiek J, Takla G, Bartnitzke S, Brandt G, Chilla R, Haubrich J (1989). Relationship of cytogenetic subtypes of salivary gland pleomorphic adenomas with patient age and histologic type. Cancer 64:876-880. DOI
Wolf J, Pawlita M, Bullerdiek J, zur Hausen H (1989). Establishment of a hybrid cell system between malignant Burkitt's lymphoma cells and nonmalignant lymphoblastoid cells. Hamatol Bluttransfus 32:220-222. DOI
Bullerdiek J, Chilla R, Haubrich J, Meyer K, Bartnitzke S (1988). A causal relationship between chromosomal rearrangements and the genesis of salivary gland pleomorphic adenomas. Arch Otorhinolaryngol 245:244-249. DOI
Bullerdiek J, Haubrich J, Meyer K, Bartnitzke S (1988). Translocation t(11;19)(q21;p13.1) as the sole chromosome abnormality in a cystadenolymphoma (Warthin's tumor) of the parotid gland. Cancer Genet Cytogenet 35:129-132. DOI
Rommel B, Hutter KJ, Bullerdiek J, Bartnitzke S, Goerttler K, Schloot W (1988). Identification of flow-sorted chromosomes by G-banding and in situ hybridization. Cytometry 9:504-507. DOI
Bullerdiek J, Bartnitzke S, Weinberg M, Chilla R, Haubrich J, Schloot W (1987). Rearrangements of chromosome region 12q13→q15 in pleomorphic adenomas of the human salivary gland (PSA). Cytogenet Cell Genet 45:187-190. DOI
Bullerdiek J, Böschen C, Bartnitzke S (1987). Aberrations of chromosome 8 in mixed salivary gland tumors--cytogenetic findings on seven cases. Cancer Genet Cytogenet 24:205-212. DOI
Bullerdiek J, Raabe G, Bartnitzke S, Böschen C, Schloot W (1987). Structural rearrangements of chromosome Nr 8 involving 8q12--a primary event in pleomorphic ademona of the parotid gland. Genetica 72:85-92. DOI
Bullerdiek J, Raabe G, Böschen C, Bartnitzke S (1987). Translocation (3;8;8)(p22 or p23;p23;q12) in a case of pleomorphic adenoma: similarity to a primary cytogenetic abnormality detected in an endometrial adenocarcinoma. Cancer Genet Cytogenet 27:177-180. DOI
Bullerdiek J, Dittmer J, Faehre A, Bartnitzke S (1986). An improved method for in situ nick translation of human chromosomes with biotin 11-labelled dUTP detected by biotinylated alkaline phosphatase. Cytobios 45:35-43.
Bullerdiek J, Dittmer J, Faehre A, Bartnitzke S (1986). Mechanisms of in situ nick translation of chromosomes using restriction endonucleases. Cytobios 47:33-44.
Djalali M, Steinbach P, Bullerdiek J, Holmes-Siedle M, Verschraegen-Spae MR, Smith A (1986). The significance of pericentric inversions of chromosome 2. Hum Genet 72:32-36. DOI
Bullerdiek J, Bartnitzke S (1985). The deleted long arm of chromosome 6: a secondary chromosome abnormality in solid tumors and lack of congenital aberrations monosomic for part of the critical segment? Cancer Genet Cytogenet 18:183-185. DOI
Bullerdiek J, Bartnitzke S, Kahrs E, Schloot W (1985). Cytogenetic observations on two ovarian carcinomas with double minutes, one with a 6q- marker chromosome. Cytobios 42:15-24.
Bullerdiek J, Bartnitzke S, Kahrs E, Schloot W (1985). Further evidence for nonrandom chromosome changes in carcinoma cells--a report of 28 cases. Cancer Genet Cytogenet 16:33-43. DOI

Bullerdiek J, Bartnitzke S, Lamprecht G (1985). A computer program for the simulation of colony-like proliferation of fibroblasts and their cell cycle behavior. Comput Methods Programs Biomed 20:95-100. DOI
Bullerdiek J, Dittmer J, Faehre A, Bartnitzke S, Kasche V, Schloot W (1985). A new banding pattern of human chromosomes by in situ nick translation using ECO RI and biotin-dUTP. Clin Genet 28:173-176. DOI
Bullerdiek J, Heyat M, Bartnitzke S, Claussen U, Schloot W (1985). The pipette-method: its application to cytogenetic studies of tumor cells cloned in semisolid media. Anticancer Res 5:411-413.
Bullerdiek J, Bartnitzke S, Pahlke R (1984). Perizentrische Inversion des Y-Cchromosoms als Ausschlusskonstellation. Anthropol Anz 42:67-72.
Bullerdiek J, Bartnitzke S, Schloot W (1983). Cells with double minutes divided into two categories. Cancer Genet Cytogenet 9:301-304. DOI
Bartnitzke S, Bullerdiek J, Wuestenberg B, Schloot W (1982). In vitro selection of tumor cells obtained from patients with ovarian carcinoma. A cytogenetic study. Anticancer Res 2:75-78.
Bullerdiek J, Bartnitzke S (1982). Die Bedeutung der menschlichen Zytogenetik für Untersuchungen zur Evolution der Hominiden. Anthropol Anz 40:81-89.
Bullerdiek J, Bartnitzke S (1982). Hypotonic treatment in visual and automatic chromosome analysis. Clin Genet 22:150. DOI
Bartnitzke S, Bullerdiek J, Schloot W (1981). Effects of hypotonic treatment on human metaphase chromosome length. Cytobios 31:75-80.
Bullerdiek J, Bartnitzke S, Schloot W (1979). A rapid and simple sandwich-method used for chromosome analysis from small fetal and adult biopsy specimens. Clin Genet 16:433-437. DOi

Top

Humangenetik Universität Bremen